[{"Element":"<div class=\"WordSection1\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS<\/span><\/b><\/p> <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\r color:green'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" id=\"Bild 1\" src=\"Alpivab%20EN%20PI%20clean_files\/image002.png\" width=\"22\"\/><\/span><span lang=\"EN-GB\">This medicinal product is subject\r to additional monitoring. This will allow quick identification of new safety\r information. Healthcare professionals are asked to report any suspected adverse\r reactions. See section 4.8 for how to report adverse reactions.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">1.       NAME OF <\/span><\/b><b><span lang=\"EN-GB\">THE\r MEDICINAL PRODUCT<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab 200 mg\r concentrate for solution for infusion<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 20 mL\r vial of concentrate contains 200 mg peramivir.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 mL concentrate\r for solution for infusion contains 10 mg peramivir (anhydrous base).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Excipients\r with known effect<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each mL of\r concentrate contains 0.154 millimole (mmol) sodium, which is 3.54 mg\r of sodium.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\r list of excipients, see section 6.1.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL FORM<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Concentrate for\r solution for infusion.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clear,\r colourless, solution.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       <\/span><\/b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab is\r indicated for the treatment of uncomplicated influenza in adults and children\r from the age of 2 years (see sections 4.4 and 5.1).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">4.2     Posology\r and method of administration<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Posology<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">Alpivab should be administered as a single intravenous dose within\r 48 hours of the onset of symptoms of influenza.<\/span><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">The recommended single intravenous dose of peramivir depends on age\r and body weight as shown in Table 1.<\/span><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal\"><a name=\"_Hlk506883324\"><b><span lang=\"EN-GB\">Table 1: Peramivir\r dose based on age and body weight <\/span><\/b><\/a><\/p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\"> <tr style=\"height:.4in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:.4in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><b><span lang=\"EN-GB\">Age and\r   body weight<\/span><\/b><\/p> <\/td> <td style=\"width:201.3pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.4in\" width=\"268\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><b><span lang=\"EN-GB\">Recommended\r   single dose<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Children aged\r   from 2 years and &lt;50 kg<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">12 mg\/kg<\/span><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Children aged\r   from 2 years and \u226550 kg body weight<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Adults and\r   adolescents (13 years and older)<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <\/table> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\r adjustment is required based on age (see sections 4.4 and 5.2).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503790927\"><\/a><a name=\"_Hlk499654234\"><i><span lang=\"EN-GB\">Renal impairment<\/span><\/i><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503874094\"><span lang=\"EN-GB\">The dose should be reduced for adults and adolescents (13 years and\r older) with absolute glomerular filtration rate (GFR) below 50 mL\/min as\r shown in Table 2 (see sections 4.4 and 5.2). <\/span><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoCaption\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\r margin-left:.6in;text-indent:-.6in;line-height:normal\"><a name=\"_Ref499728619\"><span style=\"font-size:11.0pt\">Table<\/span><\/a><span style=\"font-size:11.0pt\"> 2: Peramivir\r dose for adults and adolescents (from 13 years and 50 kg) based on absolute GFR<\/span><\/p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\"> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><b><span lang=\"EN-GB\">Absolute Glomerular Filtration Rate (GFR)*<\/span><\/b><\/p> <\/td> <td style=\"width:237.3pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><b><span lang=\"EN-GB\">Recommended single dose<\/span><\/b><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">\u226550<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">30 to 49<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">300 mg<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">10 to 29<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">200 mg<\/span><\/p> <\/td> <\/tr> <\/table> <p class=\"MsoNormal\"><span lang=\"EN-GB\">*Absolute GFR not adjusted for body surface\r area<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In adults and adolescents (from 13 years and 50 kg) with chronic\r renal impairment maintained on haemodialysis, peramivir should be administered\r after dialysis at a dose adjusted for renal function (Table 2).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"><span style=\"font-size:11.0pt\">There are insufficient clinical data available in\r children and adolescents aged less than 13 years or with body weight less than\r 50 kg with renal impairment to be able to make any dosing recommendation.<\/span><\/p> <p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"> <\/p> <p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"><i><span style=\"font-size:11.0pt\">Hepatic impairment<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\r adjustment is required in patients with hepatic impairment (see section 5.2).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk500172668\"><i><span lang=\"EN-GB\">Paediatric population<\/span><\/i><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of peramivir in children aged under 2 years\r has not yet been established. No data are available.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Method of\r administration<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab is administered\r via intravenous infusion for 15 to 30 minutes. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before\r administration, see section 6.6.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.3     Contraindications<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\r to the active substance or to any of the excipients listed in section 6.1.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Serious hypersensitivity<\/span><\/u><u><span lang=\"EN-GB\"> r<\/span><\/u><u><span lang=\"EN-GB\">eactions<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Anaphylactic\r reactions and serious skin reactions (including erythema multiforme, toxic\r epidermal necrolysis and Stevens-Johnson syndrome) have been reported with peramivir\r (see section 4.8). If any hypersensitivity reaction occurs during infusion of peramivir,\r the infusion must be stopped immediately and appropriate management should be\r instituted.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Neuropsychiatric\r events<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Delirium,\r hallucinations and abnormal behaviour have been reported in patients with\r influenza who were receiving peramivir. These events were reported primarily\r among paediatric patients and often had an abrupt onset and rapid resolution.\r The contribution of peramivir to these events has not been established.\r Patients with influenza should be closely monitored for signs of abnormal behaviour.\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\r normal\">Reduced renal function<\/span><\/u><\/p> <p class=\"MsoBodyText\"><s><u><span lang=\"EN-GB\" style=\"color:red;font-style:normal\"><\/span><\/u><\/s><\/p> <p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Acute\r renal failure, renal failure, pre-renal failure, renal disorder, anuria,\r nephritis, and increased blood creatinine have been reported in patients with\r influenza who were receiving peramivir. Most of the cases occurred in elderly\r patients with comorbidities and multiple concomitant medicinal products. The\r contribution of peramivir to these events has not been established. Patients\r with influenza and already existing diseases should be closely monitored for\r renal function.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:14.0pt\"><u><span lang=\"EN-GB\">Limitations of the clinical data<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:14.0pt\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">The efficacy of peramivir as a single dose treatment for\r uncomplicated influenza was demonstrated in a single placebo-controlled study\r conducted in 300 adult patients in Japan during the 2007\/2008 influenza\r season. The recommended 600 mg single intravenous dose resulted in shortening\r of the median time to alleviation of symptoms by 21 hours (see section 5.1).<\/span><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Available data\r do not support a conclusion that peramivir is effective in patients with\r influenza B or in patients with complicated influenza.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Resistance to peramivir<\/span><\/u><\/p> <p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Influenza A\/H1N1 viruses that contain the\r H275Y mutation have reduced susceptibility to peramivir and oseltamivir. In a\r clinical trial, no statistically significant clinical benefit could be\r demonstrated for peramivir over placebo in patients infected with the A\/H1N1\r virus containing the H275Y mutation. Available information on influenza drug\r susceptibility should be taken into account when deciding whether to use peramivir\r (see section 5.1). <\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Risk of bacterial\r infections<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\r evidence for efficacy of peramivir in any illness caused by agents other than\r influenza viruses. Serious bacterial infections may begin with influenza-like\r symptoms or may coexist with or occur as complications during the course of\r influenza. Peramivir has not been shown to prevent such complications. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Excipients<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">This medicinal product contains 212.4 mg sodium per 3 vials,\r equivalent to 10.6% of the World Health Organization (WHO) recommended maximum\r daily intake of 2 g sodium for an adult.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products\r and other forms of interaction<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The potential\r for interactions of peramivir with other medicines is low, based on the known\r elimination pathway of peramivir. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Live attenuated influenza vaccines are not\r recommended to be used until 48 hours following Alpivab administrationdue to a theoretical risk that peramivir could reduce\r the immunogenicity of the vaccine.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.6     <\/span><\/b><b><span lang=\"EN-GB\">Fertility, p<\/span><\/b><b><span lang=\"EN-GB\">regnancy and lactation<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Pregnancy<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no or\r limited amount of data (less than 300 pregnancies outcomes) from the use of\r peramivir in pregnant women. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies\r do not indicate direct or indirect harmful effects with respect to reproductive\r toxicity (see section 5.3). <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">As a\r precautionary measure, it is preferable to avoid the use of peramivir during\r pregnancy.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk506829124\"><u><span lang=\"EN-GB\">Breast-feeding<\/span><\/u><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><span style=\"color:black\">Available\r pharmacodynamic\/toxicological data in animals have shown excretion of peramivir\r in milk (see section 5.3).<\/span><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">A risk\r to the newborns\/infants cannot be excluded.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must\r be made whether to discontinue breast-feeding or to discontinue\/abstain from peramivir\r therapy taking into account the benefit of breast-feeding for the child and the\r benefit of therapy for the woman.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Fertility<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No human data on\r the effect of peramivir on fertility are available. Peramivir had no effects on\r mating or fertility in animal studies (see section 5.3). <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use\r machines<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir has no\r or negligible influence on the ability to drive and use machines.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;page-break-after:avoid;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Summary of the safety profile<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most important\r serious adverse reactions associated with permivir in patients are anaphylaxis\r and <\/span><span lang=\"EN-GB\">skin reactions, including erythema multiforme and\r Stevens-Johnson Syndrome. <\/span><\/p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">Among 467 adult\r subjects with uncomplicated influenza who received a single intravenous dose of\r <\/span><span lang=\"EN-GB\">peramivir<\/span><span lang=\"EN-GB\"> 600 mg in\r clinical trials, the most commonly observed adverse reactions were neutrophil\r count decreased (3.2 %) and nausea (2.4 %). <\/span><\/p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Tabulated list of\r adverse reactions<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Frequencies are\r defined as very common (\u22651\/10), common (\u22651\/100 to &lt;1\/10),\r uncommon (\u22651\/1000 to &lt;1\/100), rare (\u22651\/10,000 to &lt;1\/1000),\r very rare (&lt;1\/10,000).<\/span><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><a name=\"_Hlk498529576\"><b><span lang=\"EN-GB\">Table 3: <span style=\"color:black;background:white\">Adverse\r reactions in studies investigating peramivir for treatment of uncomplicated\r influenza in adults <\/span><\/span><\/b><\/a><\/p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.5pt;border-collapse:collapse;border:none\" width=\"648\"> <thead> <tr style=\"height:28.5pt\"> <td rowspan=\"2\" style=\"width:1.5in;border:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:28.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">System\r    Organ Class (SOC)<\/span><\/b><\/p> <\/td> <td colspan=\"4\" style=\"width:5.25in;border:solid windowtext 1.0pt;\r    border-left:none;padding:0in 5.4pt 0in 5.4pt;height:28.5pt\" width=\"504\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Adverse Reaction According to Frequency*<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:15.75pt\"> <td style=\"width:1.25in;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Common<\/span><\/b><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Uncommon<\/span><\/b><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rare<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Unknown<\/span><\/b><\/p> <\/td> <\/tr> <\/thead> <tr style=\"height:29.25pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Blood and\r   lymphatic system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">neutrophil\r   count decreased<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:29.25pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Immune\r   system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">anaphylactic\r   reaction*, anaphylactic shock*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:137.2pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Metabolism\r   and nutrition disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">blood lactate\r   dehydrogenase increased<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">decreased\r   appetite, blood albumin decreased, blood chloride increased, blood glucose\r   decreased, blood lactate dehydrogenase decreased, blood potassium increased,\r   blood sodium increased, blood uric acid increased, protein total increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:137.2pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Psychiatric\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">insomnia<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">abnormal\r   behaviour*, delirium*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nervous\r   system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">hypoaesthesia,\r   paraesthesia<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:15.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eye\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vision blurred<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Cardiac\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">electrocardiogram\r   QT prolonged<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:40.0pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">nausea,\r   vomiting<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">abdominal pain\r   upper, abdominal discomfort, gastritis<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:40.0pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:75.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hepatobiliary\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">increased\r   gamma-glutamyltransferase<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:75.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">liver\r   disorder*, alanine aminotransferase increased*, aspartate aminotransferase\r   increased* <\/span><\/p> <\/td> <\/tr> <tr style=\"height:45.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\r   subcutaneous tissue disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">dermatitis,\r   drug eruption, eczema, urticaria<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:45.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">erythema\r   multiforme<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">dermatitis\r   exfoliative*, Stevens-Johnson syndrome*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:43.5pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\r   and connective tissue disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">arthralgia,\r   blood creatine phosphokinase increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:43.5pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:63.8pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Renal and\r   urinary disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">blood urea\r   increased, blood present in urine, urobilin present in urine, blood\r   creatinine increased, urine ketone body increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:63.8pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">acute kidney\r   injury*, renal impairment*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:43.5pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\r   disorders and administration site conditions<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">chest\r   discomfort, fatigue<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:43.5pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <\/table> <p class=\"TableTextFootnote\"><span style=\"color:windowtext\">*These events\r reported from post-authorization use occurred with different dosage and dosing\r schedule to that described in the SmPC.<\/span><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">Paediatrics<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">In\r paediatric subjects (age 2 to 17 years) with uncomplicated influenza enrolled\r in a clinical trial, the safety profile of peramivir was similar to that\r reported in adults. Common a<\/span><span lang=\"EN-GB\">dverse reactions not\r reported in adults were injection site rash, pyrexia, tympanic membrane\r hyperaemia, psychomotor hyperactivity, and pruritus. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\r medicinal product is important. It allows continued monitoring of the\r benefit\/risk balance of the medicinal product. Healthcare professionals are\r asked to report any suspected adverse reactions via the national reporting\r system listed in <\/span><span lang=\"EN-GB\"><a href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Template_or_form\/2013\/03\/WC500139752.doc\">Appendix\r V<\/a><\/span><span lang=\"EN-GB\">.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\r none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\r none\"><span lang=\"EN-GB\">There is no experience of acute overdose with peramivir\r in humans. Treatment of an overdose should consist of general supportive\r measures including monitoring of vital signs and observation of the clinical\r status of the patient. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Peramivir is cleared by renal excretion and can be cleared by haemodialysis.\r There is no specific antidote to treat an overdose of this medicine.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL\r PROPERTIES<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic\r properties<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Antivirals for systemic use,\r neuraminidase inhibitors ATC code<\/span><b><span lang=\"EN-GB\">: <\/span><\/b><span lang=\"EN-GB\">J05AH03<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Mechanism of action<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Peramivir is an inhibitor of influenza virus neuraminidase, an\r enzyme that releases viral particles from the plasma membrane of infected cells\r and is also important for viral entry into uninfected cells, which causes further\r spread of infectious virus in the body.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><u><span lang=\"EN-GB\">In-vitro<\/span><\/u><\/i><u><span lang=\"EN-GB\"> activity <\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Neuraminidase\r inhibition occurred at very low peramivir concentrations <i>in-vitro<\/i>, with\r median inhibitory concentration 50% (IC<sub>50<\/sub>) values of 0.13 nanomolar\r (nM) to 0.99 nM against influenza A and B strains.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><a name=\"_Hlk503779250\"><i><span lang=\"EN-GB\">Resistance<\/span><\/i><\/a><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">In a clinical\r trial in which 245 subjects <a name=\"_Hlk500240383\">were infected at baseline\r with influenza<\/a> A\/H1N1 containing the H275Y mutation, the median baseline IC<sub>50<\/sub>\r values for peramivir, oseltamivir and zanamivir were 51.0 nM, 487.6 nM and 0.95\r nM, respectively. <\/span><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">In clinical\r trials, H275Y was the only resistance-associated treatment-emergent mutation in\r the neuraminidase gene that occurred in virus obtained from more than one\r peramivir-treated subject (in 9 of 481[1.9 %] infected with the A\/H1N1\r influenza virus). <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Cross resistance<\/span><\/i><\/p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;text-align:justify;text-justify:\r inter-ideograph;line-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;\r font-family:\"Times New Roman\",serif'>The H275Y substitution is associated with\r reduced susceptibility to peramivir and oseltamivir. Cross-resistance between\r peramivir and each of oseltamivir and zanamivir may also occur. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><s><span lang=\"EN-GB\" style=\"color:red\"><\/span><\/s><\/p> <p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Clinical\r studies<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><a name=\"_Hlk498508026\"><i><span lang=\"EN-GB\">Uncomplicated influenza in adults<\/span><\/i><\/a><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">A randomised, multicentre, double-blind\r trial conducted in Japan evaluated a single intravenous administration of\r peramivir 300 mg or 600 mg, or placebo administered over\r 30 minutes in subjects 20 to 64 years of age withuncomplicated influenza. Subjects were eligible if\r they had fever greater than 38 <a name=\"_Hlk503778028\">\u00b0C<\/a> and a\r positive rapid antigen test for influenza virus, accompanied by at least two of\r the following symptoms: cough, nasal symptoms, sore throat, myalgia,\r chills\/sweats, malaise, fatigue or headache. <\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Study treatment was started within\r 48 hours of onset of symptoms. Subjects participating in the trial were\r required to self-assess their influenza symptoms as \u201cnone\u2019, \u2018mild\u2019, \u2018moderate\u2019\r or \u2018severe\u2019 twice daily. The primary endpoint, time to alleviation of symptoms,\r was defined as the number of hours from initiation of study drug until the\r start of the 24 hour period in which all seven symptoms of influenza\r (cough, sore throat, nasal congestion, headache, feverishness, myalgia and\r fatigue) were either absent or present at a level no greater than mild for at\r least 21.5 hours.<\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">The intent to treat influenza population\r (ITTI) included 296 subjects with influenza confirmed by polymerase chain\r reaction (PCR). Among the 97 subjects enrolled in the peramivir\r 600 mg dose group, 99 % were infected with influenza A virus (subtypes\r H1 and H3; 71 % and 26 %, respectively) and 1 % with influenza B\r virus. At enrollment 85 % of the 296 subjects had a composite influenza\r symptom score &lt;15. The mean temperature at enrolment was 38.6 \u00b0C\r (axillary). Key efficacy results are presented in Table 4.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><b><span lang=\"EN-GB\">Table 4: Key\r efficacy results from study 0722T0621 (ITTI Population)<\/span><\/b><\/p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:418.1pt;border-collapse:collapse\" width=\"557\"> <tr> <td style=\"width:45.68%;border:inset 1.0pt;border-bottom:\r   solid windowtext 1.0pt;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"><\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span style=\"color:black\">Peramivir 600 mg<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">n=97<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span style=\"color:black\">Placebo<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">n=100<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:45.68%;border:inset 1.0pt;border-top:\r   none;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"> <p class=\"MsoNormal\" style=\"line-height:normal\">Time to alleviation of symptoms<\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">median\r   (hours)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">(95 %\r   CI)<\/span><\/p> <\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">59.9<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(54.4, 68.1)<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">81.8<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(68.0, 101.5)<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:45.68%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">Time\r   to recovery of normal temperature median (hours)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">(95 %\r   CI)<\/span><\/p> <\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">30.2<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(25.9, 31.9)<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">42.4<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(32.9, 46.5)<\/span><\/p> <\/td> <\/tr> <\/table> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">CI = Confidence\r Interval <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Uncomplicated\r influenza in paediatric subjects aged 2-17 years<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety of peramivir\r was evaluated in a randomised, active-controlled study of 110 subjects\r with uncomplicated influenza who received open label treatment with a single\r dose of peramivir (600 mg for subjects 13 to 17 years of age and 12 mg\/kg\r up to a maximum dose of 600 mg in subjects 2 to 12 years of age) or oral\r oseltamivir administered twice daily for 5 days. <\/span><span lang=\"EN-GB\">The\r ITTI population included 84 subjects with influenza confirmed by PCR. Among the\r 93 subjects enrolled in the peramivir dose group, 43% were infected with\r influenza A virus (subtypes H1 and H3; 54 % and 46 %, respectively) and 27%\r with influenza B virus. <\/span><span lang=\"EN-GB\">Randomisation was 4:1 for peramivir\r and oseltamivir. Treatment was given or commenced within 48 hours of onset\r of symptoms of influenza. Efficacy (time to resolution of fever; time to\r resolution of influenza symptoms, viral shedding, virus susceptibility) was a\r secondary endpoint.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Subjects\r receiving peramivir experienced a median time to alleviation of their combined\r influenza symptoms of 79.0 hours and the median time to recovery to normal\r temperature (less than 37 \u00b0C) was approximately 40.0 hours.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly\r patients<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clinical trials\r in which single intravenous doses of peramivir were administered to patients\r with uncomplicated influenza included few subjects aged 65 and over (n=10).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred\r the obligation to submit the results of studies with Alpivab in one or more\r subsets of the paediatric population for the treatment of influenza (see\r section 4.2 for information on paediatric use).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Absorption<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetic parameters following intravenous (IV) administration of peramivir\r (0.17 to 2 times the recommended dose) showed a linear relationship\r between dose and exposure parameters (maximum serum concentration [C<sub>max<\/sub>]\r and area under the curve [AUC]). Following intravenous administration of a\r single dose of peramivir 600 mg over 30 minutes, C<sub>max<\/sub> was\r reached at the end of infusion. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Distribution<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In-vitro<\/span><\/i><span lang=\"EN-GB\"> binding of peramivir to human plasma proteins is less than 30 %.\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on a\r population pharmacokinetic analysis, the central volume of distribution was\r 12.56 L.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Biotransformation<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir is not\r significantly metabolised in humans.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The elimination half-life of peramivir following IV administration\r to healthy subjects of 600 mg as a single dose is approximately 20 hours.\r The major route of elimination of peramivir is via the kidney. Renal clearance\r of unchanged peramivir accounts for approximately 90 % of total clearance.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Race<\/span><\/i><\/p> <p class=\"MsoNormal\"><a name=\"_Hlk498601677\"><span lang=\"EN-GB\">In simulations of a\r single dose of 600 mg, the predicted AUC in Asians (AUC<sub>0-24<\/sub> 88,800\r ng<\/span><\/a><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">h\/mL) was slightly\r higher as compared to Non-Asians (AUC<sub>0-24<\/sub> 77,200 ng<\/span><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">h\/mL).  <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Gender<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetics of peramivir following a 600 mg intramuscular (IM) injection was\r similar in males and females with AUC<sub>0-\u221e<\/sub> of 76,600 ng\u2022hr\/mL\r and 101,000 ng\u2022hr\/mL, respectively, and C<sub>max<\/sub> of 27,760 ng\/mL\r and 34,710 ng\/mL, respectively.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503609111\"><i><span lang=\"EN-GB\">Paediatrics<\/span><\/i><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk497130888\"><span lang=\"EN-GB\">The pharmacokinetics of peramivir has been evaluated in a study in\r paediatric subjects 2 to 17 years of age with uncomplicated influenza.\r Pharmacokinetic sampling in this study was limited to approximately 3 hours\r after administration of peramivir. Pharmacokinetics of peramivir in subjects 2\r to 17 years of age (administered 12 mg\/kg or 600 mg according to age and\r body weight) and in healthy adults (administered 600 mg) was similar\r (Table 5). <\/span><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><b><span lang=\"EN-GB\">Table 5: Pharmacokinetic\r parameters in paediatric subjects <\/span><\/b><\/p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <tr style=\"height:28.3pt\"> <td style=\"width:103.25pt;border:solid windowtext 1.0pt;padding:\r   0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">Age Group<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><\/p> <\/td> <td style=\"width:.5in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">N<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">C<sub>max<\/sub> (ng\/mL)<\/span><\/b><\/p> <\/td> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">AUC<sub>last<\/sub> (ng<\/span><\/b>\u2022<b><span style=\"font-size:11.0pt\">h\/mL)<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:17.5pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">2 years - &lt;7 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">28<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">53,600 (26,200)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">74,000 (30,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:19.3pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:19.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:19.3pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:19.3pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">47,400<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:19.3pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">68,100<\/span><\/p> <\/td> <\/tr> <tr style=\"height:14.35pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:14.35pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:14.35pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:14.35pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">48.9<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:14.35pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">40.6<\/span><\/p> <\/td> <\/tr> <tr style=\"height:16.15pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">7 years - &lt;13 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:16.15pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">39<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">66,800 (35,400)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:16.15pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">87,000 (40,800)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:18.4pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:18.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:18.4pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:18.4pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">61200<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:18.4pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">81,000<\/span><\/p> <\/td> <\/tr> <tr style=\"height:15.25pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.25pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.25pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.25pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">53.0<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.25pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">46.8<\/span><\/p> <\/td> <\/tr> <tr style=\"height:27.4pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">13 years - &lt;18<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:27.4pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">20<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">54,300 (17,900)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:27.4pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">72,400 (20,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.5pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">51,500<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">69,500<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">33.0<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">27.6<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">2 years - &lt;18 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">87<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">59,700 (29,700)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">79,500 (34,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">54,200<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">74,000<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">49.8<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">42.7<\/span><\/p> <\/td> <\/tr> <\/table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SD = Standard\r Deviation; CV = Coefficient of Variation<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\" style=\"color:red\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The pharmacokinetics\r of peramivir was evaluated in 20 elderly subjects (&gt;65 years of age)\r following a single 4 mg\/kg IV dose of peramivir. The elderly subjects\r enrolled were aged 65 to 79 years, with a mean age of 70.1 years, with creatinine\r clearance (Cockcroft-Gault calculation) CrCl<sub>cg<\/sub> ranging from 82.8\r mL\/min to 197.9 mL\/min. The <\/span><span lang=\"EN-GB\">pharmacokinetics in elderly\r subjects was similar to non-elderly subjects.<\/span><span lang=\"EN-GB\"> Mean peak\r concentrations of peramivir were approximately 10 % higher in elderly\r subjects following administration of a single dose when compared to young\r adults (22,647 vs. 20,490 ng\/mL, respectively). Exposure (AUC<sub>0-12<\/sub>)\r to peramivir following a single dose was approximately 33 % higher in\r elderly subjects compared to young adults (61,334 vs. 46,200 ng<\/span><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">hr\/mL, respectively).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Renal impairment<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a study in\r subjects with various degrees of renal impairment and subjects with normal\r renal function, a single 2 mg\/kg IV dose of peramivir was administered.\r Serum creatinine measurements were used to calculate creatinine clearance\r (Cockcroft-Gault equation). The mean AUC<sub>0-<\/sub><\/span><sub><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b5<\/span><\/sub><span lang=\"EN-GB\"> was\r increased by 28 %, 302 % and 412 % in subjects with creatinine clearance of 50\u201179,\r 30\u201149 and 10\u201129 mL\/min, respectively. Haemodialysis initiated at 2 hours\r after dosing reduced systemic exposure of peramivir by 73 to 81 %.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Hepatic impairment<\/span><\/i><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetics of peramivir in subjects with hepatic impairment has not been\r studied. No clinically relevant alterations to peramivir pharmacokinetics are\r expected in patients with hepatic impairment based on the route of peramivir\r elimination.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety\r data<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><span lang=\"EN-GB\">Peramivir was not teratogenic in embryo-fetal\r development studies in rats and rabbits and had no effects on mating or\r fertility in rats up to 600 mg\/kg\/day, at which exposures were\r approximately 8\u2011fold of those in humans at the clinically recommended\r dose. However, in an embryo-foetal development study in rats, in which dams\r received continuous infusions of peramivir from day 6\u201117 of gestation at\r does of 50, 400 or 1000 mg\/kg\/day, dose related increases in the\r incidences of reduction of the renal papillae and dilatation of the ureters\r were observed. The teratological importance of these findings is unclear.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carcinogenicity studies by intravenous injection of peramivir were\r not performed. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir was\r not mutagenic or clastogenic in a battery of <i>in-vitro<\/i> and <i>in-vivo<\/i>\r assays.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Acute renal\r necrosis was found in rabbits at doses \u2265 200 mg\/kg with a clear no\r observed adverse effect level (NOAEL) established in multiple studies at 100 mg\/kg\/day.\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Two-week oral\r toxicity studies were conducted in juvenile rats and rabbits, and a four-week\r IV toxicity study was conducted in juvenile rats. In general, nephrotoxicity\r was observed in rabbits, no unexpected toxicity was observed, and no other\r target organ toxicity was identified in juvenile animals.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.1     List of excipients<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium hydroxide\r (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal\"><span lang=\"EN-GB\">Hydrochloric acid (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.2     Incompatibilities<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\r product must not be mixed with other medicinal products except those mentioned\r in section 6.6.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.3     Shelf life<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Unopened vial<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5 years<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">After\r dilution<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Chemical and physical in-use stability has\r been demonstrated for 72 hours at 5 \u00baC and 25 \u00baC.<\/span><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">From a microbiological point of view, the\r product, once diluted, should be used immediately.<\/span><span lang=\"EN-GB\">If not used immediately in-use storage times and conditions prior to\r use are the responsibility of the user and would normally not be longer than 24\r hours at 2 \u00baC to 8 \u00baC, unless dilution has taken place in controlled and\r validated aseptic conditions.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not refrigerate\r or freeze.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage\r conditions after dilution of the medicinal product, see section 6.3.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Clear glass vial (Type I) with a coated bromobutyl-rubber stopper, aluminium\r overseal and flip-off cap. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 3\r single-use vials.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special\r precautions for disposal and other handling<\/span><\/b><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Aseptic technique should be used during the preparation of Alpivab\r to prevent inadvertent microbial contamination. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The following\r steps should be followed to prepare a diluted solution of peramivir:<\/span><\/p> <p class=\"MsoListParagraphCxSpFirst\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\r line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Check\r the seal of each vial. Do not use if seal opening is broken or missing.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Visually\r inspect the peramivir concentrate 10 mg\/mL. It must be colourless and\r without particulate matter. <\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a\r patient receives 600 mg peramivir the required volume of peramivir\r concentrate is 60 mL (3 vials with 20 mL each). In the case of a\r 300 mg peramivir dose, 30 mL (1\u00bd vials) of peramivir concentrate\r is needed and for a 200 mg dose, only 20 mL (1 vial). Fractions\r of a vial may be needed for appropriate dose adjustments in children with a\r bodyweight of less than 50 kg.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Add\r the measured volume of peramivir concentrate into the infusion container.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dilute\r the required dose of peramivir concentrate in sodium chloride 9 mg\/mL (0.9 %)\r or 4.5 mg\/mL (0.45 %) solution for infusion, 5 % dextrose or\r Ringer lactate solution to a volume of 100 mL.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Administer\r the diluted solution via intravenous infusion for 15 to 30 minutes.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Once\r a diluted peramivir solution has been prepared, administer immediately or store\r in a refrigerator (2 \u00b0C to 8 \u00b0C) for up to 24 hours. If\r refrigerated, allow the diluted peramivir solution to reach room temperature,\r then administer immediately.<\/span><\/p> <p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0in;margin-right:0in;\r margin-bottom:0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Discard\r any unused diluted solution of peramivir after 24 hours.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\r medicinal product or waste material should be disposed of in accordance with\r local requirements.<\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">BioCryst UK Ltd,\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">c\/o Morgan Lewis\r &amp; Bockius<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Condor House, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5-10 St. Paul's\r Churchyard, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">London EC4M 8AL <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 (<\/span>0)\r 20 3289 9824<\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Fax: +44 (<\/span><span style=\"color:#222222\">0) 20 3725 7789<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">E<\/span><span lang=\"EN-GB\">-mail: safety@biocryst.com<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><a name=\"_Hlk506824658\"><b><span lang=\"EN-GB\">8.       MARKETING\r AUTHORISATION NUMBER(S) <\/span><\/b><\/a><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU\/1\/18\/1269\/001<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION\/RENEWAL OF THE\r AUTHORISATION<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\r website of the European Medicines Agency <span style=\"color:blue\">http:\/\/www.ema.europa.eu<\/span>.<br clear=\"all\" style=\"page-break-before:always\"\/> <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\r normal\"><b><span lang=\"EN-GB\">A.        MANUFACTURER(S) RESPONSIBLE FOR BATCH\r RELEASE<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.9pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\r normal\"><b><span lang=\"EN-GB\">B.        CONDITIONS OR RESTRICTIONS REGARDING\r SUPPLY AND USE<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.95pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\r normal\"><b><span lang=\"EN-GB\">C.        OTHER CONDITIONS AND REQUIREMENTS OF THE\r MARKETING AUTHORISATION<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\r normal\"><b><span lang=\"EN-GB\">D.        <span style=\"text-transform:uppercase\">conditions\r or restrictions with regard to the safe and effective use of the medicinal\r product<\/span><\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\r normal\"><\/p> <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) RESPONSIBLE FOR BATCH\r RELEASE<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:7.0pt;\r margin-left:6.35pt;line-height:14.0pt;text-autospace:none\"><u><span lang=\"EN-GB\" style=\"color:black\">Name and address of the manufacturer(s) responsible for\r batch release<\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\r margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">Seqirus Vaccines Ltd<br\/>\r Gaskill Road<br\/>\r Speke<br\/>\r Liverpool<br\/>\r L24 9GR<br\/>\r UNITED KINGDOM<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.<\/span><\/b><\/a><b><span lang=\"EN-GB\">      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE <\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.0pt;margin-bottom:0in;\r margin-left:6.35pt;margin-bottom:.0001pt;line-height:14.0pt;text-autospace:\r none\"><span lang=\"EN-GB\" style=\"color:black\">Medicinal product subject to medical\r prescription.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE\r MARKETING AUTHORISATION<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><b><span lang=\"EN-GB\">Periodic Safety Update Reports<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of periodic safety update reports\r for this medicinal product are set out in the list of Union reference dates\r (EURD list) <\/span><span lang=\"EN-GB\">provided for under Article 107c(7) of\r Directive 2001\/83\/EC and any subsequent updates published on the European\r medicines web-portal.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\r authorisation holder shall submit the first periodic safety update report for\r this product within 6 months following authorisation. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO\r THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><b><span lang=\"EN-GB\">Risk Management Plan (RMP)<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:.5in;margin-bottom:.0001pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The MAH shall perform the required pharmacovigilance activities and\r interventions detailed in the agreed RMP presented in Module 1.8.2 of the\r Marketing Authorisation and any agreed subsequent updates of the RMP.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">An updated RMP should be submitted:<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">At the request of the European Medicines Agency;<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">Whenever the risk management system is modified,\r especially as the result of new information being received that may lead to a\r significant change to the benefit\/risk profile or as the result of an important\r (pharmacovigilance or risk minimisation) milestone being reached.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p> <b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span><\/b> <p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET<\/span><\/b><\/p> <b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span><\/b> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">A. LABELLING<\/span><\/b><\/p> <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\r color:black'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span> <p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING <\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE\r MEDICINAL PRODUCT<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab\r 200 mg concentrate for solution for infusion<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">peramivir<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       STATEMENT OF\r ACTIVE SUBSTANCE(S)<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 mL\r concentrate contains 10 mg peramivir (anhydrous basis).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 20 mL\r vial contains 200 mg peramivir.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       LIST OF EXCIPIENTS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium hydroxide\r (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hydrochloric\r acid (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       PHARMACEUTICAL\r FORM AND CONTENTS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Concentrate for solution for infusion<\/span><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">3 vials<\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       METHOD AND\r ROUTE(S) OF ADMINISTRATION<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\r leaflet before use.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Intravenous use\r after dilution<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       SPECIAL WARNING\r THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\r CHILDREN<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\r sight and reach of children.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.       OTHER SPECIAL\r WARNING(S), IF NECESSARY<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.       EXPIRY DATE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.       SPECIAL\r STORAGE CONDITIONS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Do not refrigerate or freeze.<\/span><\/p> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.     SPECIAL PRECAUTIONS\r FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH\r MEDICINAL PRODUCTS, IF APPROPRIATE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">--<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.     NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">BioCryst UK Ltd,\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5-10 St. Paul's\r Churchyard, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">London, EC4M 8AL\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">UK<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.     MARKETING AUTHORISATION NUMBER(S) <\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU\/1\/18\/1269\/001\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.     BATCH NUMBER<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.     GENERAL CLASSIFICATION FOR SUPPLY<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.     INSTRUCTIONS ON USE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.     INFORMATION IN BRAILLE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">Justification for not including Braille\r accepted.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.     UNIQUE IDENTIFIER \u2013 2D BARCODE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:lightgrey\">2D barcode carrying the unique identifier included<\/span><span lang=\"EN-GB\">.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.     UNIQUE IDENTIFIER - HUMAN READABLE DATA<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">PC:<\/span><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">SN: <\/span><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">NN:<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\r color:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON\r THE IMMEDIATE PACKAGING<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">VIAL LABEL<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE\r MEDICINAL PRODUCT<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab\r 200 mg concentrate for solution for infusion<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">peramivir<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       STATEMENT OF\r ACTIVE SUBSTANCE(S)<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 mL\r concentrate contains 10 mg peramivir (anhydrous base).<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 20 mL\r vial contains 200<\/span><span lang=\"EN-GB\">mg\r peramivir.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       LIST OF EXCIPIENTS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium hydroxide\r (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hydrochloric\r acid (for pH adjustment)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       PHARMACEUTICAL\r FORM AND CONTENTS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">Concentrate for solution for infusion<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       METHOD AND\r ROUTE(S) OF ADMINISTRATION<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\r leaflet before use.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Intravenous use\r after dilution<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       SPECIAL WARNING\r THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\r CHILDREN<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\r sight and reach of children.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.       OTHER SPECIAL\r WARNING(S), IF NECESSARY<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.       EXPIRY DATE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.       SPECIAL\r STORAGE CONDITIONS<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\">Do not refrigerate or freeze.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.     SPECIAL PRECAUTIONS\r FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH\r MEDICINAL PRODUCTS, IF APPROPRIATE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">--<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.     NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">BioCryst UK Ltd,\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5-10 St. Paul's\r Churchyard, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">London, EC4M 8AL\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">UK<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.     MARKETING AUTHORISATION NUMBER(S) <\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU\/1\/18\/1269\/001\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.     BATCH NUMBER<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.     GENERAL CLASSIFICATION FOR SUPPLY<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">--<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.     INSTRUCTIONS ON USE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">--<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.     INFORMATION IN BRAILLE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#CCCCCC\">Justification for not including Braille\r accepted.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.     UNIQUE IDENTIFIER \u2013 2D BARCODE<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.     UNIQUE IDENTIFIER - HUMAN READABLE DATA<\/span><\/b><\/p> <\/div> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:5.65pt;line-height:normal\"><\/p> <b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span><\/b> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">B. PACKAGE LEAFLET<\/span><\/b><\/p> <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\r background:white\"><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Alpivab 200 mg concentrate for solution for infusion<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">peramivir<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Alpivab%20EN%20PI%20clean_files\/image003.png\" width=\"22\"\/><\/span><span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow\r quick identification of new safety information. You can help by reporting any\r side effects you may get. See the end of section 4 for how to report side\r effects.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of\r this leaflet carefully before you start using this medicine because it contains\r important information for you.<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\r again. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">If you have any further questions, ask your\r doctor or pharmacist.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">If you get any side effects, talk to your doctor\r or pharmacist.<\/span><span lang=\"EN-GB\">This includes any possible side effects not listed in this leaflet.\r See section 4.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">What is in\r this leaflet<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">1.       What Alpivab is and what it is used for <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">2.       What you need to know before you are given Alpivab <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">3.       How Alpivab is given<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">4.       Possible side effects <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">5.       How to store Alpivab <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">6.       Contents of the pack and other information<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">1.       What Alpivab is and what it is used for<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Alpivab contains the active substance peramivir which belongs to a\r group of medicines called neuraminidase inhibitors. These medicines prevent the\r influenza virus from spreading inside the body. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Alpivab is used to treat adults and children aged from 2 years\r with influenza that is not severe enough to require hospitalisation. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">2.       What you need to know before you are given\r Alpivab<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">You must not receive Alpivab<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">if you are allergic to peramivir or any of the\r other ingredients of this medicine (listed in section 6)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Warnings and precautions<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Talk to your\r doctor or pharmacist before you are given Alpivab if you have reduced kidney\r function. Your doctor may have to adjust your dose.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Tell your doctor immediately if you experience serious skin or\r allergic reactions after Alpivab is given. Symptoms may include skin or throat\r swelling, difficulty breathing, blistering rash or peeling skin. See section 4.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Tell your doctor immediately if you experience abnormal behaviour\r after Alpivab is given. Symptoms may include confusion, difficulty thinking or\r hallucinations. See section 4.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Alpivab is not recommended in children aged under 2 years.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and Alpivab<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tell your doctor or pharmacist if you are using, have recently used\r or might use any other medicines.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Live attenuated influenza vaccines should not be given until\r 48 hours after treatment with Alpivab. This is because Alpivab may prevent\r these vaccines from working well enough.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Pregnancy and breast-feeding<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tell your doctor\r if you are pregnant or breast-feeding. Your doctor will advise on whether you\r can be given Alpivab during pregnancy, or whether you are to stop\r breast-feeding for a short period after getting Alpivab.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Driving and using machines<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Alpivab is not likely to change your ability to drive and use\r machines.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Alpivab contains sodium<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"> <\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\">This medicine\r contains <span lang=\"EN-GB\">212.4 <\/span>mg sodium (main component of\r cooking\/table salt) in each dose consisting of 3 vials. This is equivalent to\r 10.6 % of the recommended maximum daily dietary intake of sodium for an adult.<s> <\/s><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><a name=\"_Hlk506897833\"><\/a><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><a name=\"_Hlk506885258\"><b><span lang=\"EN-GB\">3.       How Alpivab is\r given<\/span><\/b><\/a><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Alpivab is given by a healthcare profesional as a single dose within\r 2 days of the start of influenza symptoms. It is first diluted and then given into\r a vein  by infusion (drip), over 15 to 30 minutes.  <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoListParagraphCxSpFirst\" style=\"margin-top:0in;margin-right:-.1pt;\r margin-bottom:8.0pt;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adults\r and adolescents (13 years and older) receive 600 mg (3 Alpivab vials).<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0in;margin-right:-.1pt;\r margin-bottom:8.0pt;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children\r aged from 2 years weighing 50 kg or more receive 600 mg (3 Alpivab vials).<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-top:0in;margin-right:-.1pt;\r margin-bottom:8.0pt;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children\r aged from 2 years weighing less than 50 kg receive 12 mg per kg body weight.<\/span><\/p> <p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\r 0in;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients\r with reduced kidney function may require a reduced dose.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><s><span lang=\"EN-GB\"><\/span><\/s><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">If you have any further questions on the use of this medicine, ask\r your doctor or pharmacist<\/span><span lang=\"EN-GB\">.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.       Possible side effects<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">Like all medicines, this medicine can cause side effects, although\r not everybody gets them.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\r 6.0pt;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\">Contact your\r doctor immediately<\/span><\/b><span lang=\"EN-GB\"> if any of the following side\r effects occur:<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Rare,<\/span><\/b><span lang=\"EN-GB\"> may affect up to 1 in\r 1,000 people<\/span><\/p> <p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:\r 0in;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>severe\r skin rash with or without blisters and fever<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Not known, <\/span><\/b><span lang=\"EN-GB\">frequency cannot be estimated\r from the available data<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">very severe skin reactions, including\r Steven-Johnson syndrome and dermatitis exfoliative <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\">These\r skin reactions are life-threatening rashes with fever and blisters and can\r effect the lining of the mouth and genitals.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">severe<\/span> allergic reactions, including severe\r allergic shock reaction with features such as itchy rash, swelling of the\r throat and tongue, breathing difficulty, lightheadedness and vomiting<\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\r 6.0pt;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\">Other side effects\r occur with the following frequencies:<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Common<\/span><\/b><span lang=\"EN-GB\">, may affect up to 1 in\r 10 people<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">low levels of a white blood cell type called\r neutrophils<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.1pt;text-indent:-28.1pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">blood tests showing increased levels of lactate\r dehydrogenase<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">nausea (feeling sick), vomiting<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Uncommon<\/span><\/b><span lang=\"EN-GB\">, may affect up to 1 in\r 100 people<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">decreased appetite<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">blood tests showing decreased levels of albumin,\r glucose, lactate dehydrogenase<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">blood tests showing increased levels of\r chloride, potassium, sodium, uric acid, protein total,\r gamma-glutamyltransferase, creatine phosphokinase, urea, creatinine<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">sleeplessness<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">reduced sense of touch or sensation<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">abnormal sensation such as prickling, tingling\r and itchiness<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">blurred vision<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">prolonged time of the heart ventricle activity,\r measured in the ECG<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">upper abdominal pain, abdominal discomfort<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">inflammation of stomach lining<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">skin inflammation, eczema, rash, nettle-rash<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">joint pain<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">urobilin presented in the urine<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">increased level of urine ketone body<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">chest discomfort, fatigue<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><s><span lang=\"EN-GB\" style=\"color:#0070C0\"><\/span><\/s><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Not known<\/span><\/b><span lang=\"EN-GB\">, frequency cannot be estimated\r from the available data<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">abnormal behaviour, delirium<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">liver disorder<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">blood test showing increased levels of alanine\r aminotransferase, aspartate aminotransferase<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">acute kidney injury, reduced kidney function<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Children and Adolescents from 2 years<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">Side effects were similar to adults but also included the following:<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><b><span lang=\"EN-GB\">Common<\/span><\/b><span lang=\"EN-GB\">, may affect up to 1 in\r 10 people<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span>rash on the injection site<\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span>fever<\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span>red ear drum<\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span>restlessness<\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span style=\"font-family:Symbol\">\u00b7<\/span>itching<\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><s><span lang=\"EN-GB\" style=\"color:#0070C0\"><\/span><\/s><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Reporting of side effects<\/span><\/b><\/p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><\/p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>If you\r get any side effects, talk to your doctor or pharmacist.<\/span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>This\r includes any possible side effects not listed in this leaflet. You can also\r report side effects directly via <span style=\"background:lightgrey\">the\r national reporting system listed in <\/span><\/span><span lang=\"EN-GB\"><a href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Template_or_form\/2013\/03\/WC500139752.doc\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;background:lightgrey'>Appendix\r V<\/span><\/a><\/span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>.\r By reporting side effects you can help provide more information on the safety\r of this medicine.<\/span><\/p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">5.       How to store Alpivab<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not use this medicine after the expiry date which is stated on\r the label and carton after EXP. The expiry date refers to the last day of that\r month.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not refrigerate or freeze.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Once diluted,\r administer the prepared Alpivab solution immediately; otherwise, store <\/span><span lang=\"EN-GB\">in a refrigerator (2 \u00b0C \u2013 8 \u00b0C) for up to 24 hours. <\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       Contents of the\r pack and other information<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><b><span lang=\"EN-GB\">What Alpivab contains<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">The active substance is peramivir.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\">Each\r 20 mL vial contains <\/span><span lang=\"EN-GB\">200 mg<\/span><span lang=\"EN-GB\"> peramivir. 1 mL concentrate for solution for infusion contains\r 10 mg peramivir (anhydrous base).<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\r margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">The other ingredients are sodium chloride, water\r for injections, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH\r adjustment).<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What Alpivab looks like and contents of the pack<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab is a\r clear, colourless, sterile concentrate for solution for infusion. It is\r provided in a clear glass vial with a coated rubber stopper, aluminium overseal\r and flip-off cap. <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each carton contains\r 3 vials.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder <\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">BioCryst UK Ltd,\r <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">c\/o Morgan Lewis\r &amp; Bockius Condor House, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5-10 St. Paul's\r Churchyard, <\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">London EC4M 8AL<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">UK<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 (0) 20\r 3289 9824<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Fax: +44 (0) 20\r 3725 7789<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">E<\/span><span lang=\"EN-GB\">-mail: safety@biocryst.com<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">Manufacturer<\/span><\/b><\/p> <p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Seqirus Vaccines\r Limited<\/span><\/p> <p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Gaskill Road,\r Speke<\/span><\/p> <p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Liverpool<\/span><\/p> <p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">L24 9GR<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">UK<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was <\/span><\/b><b><span lang=\"EN-GB\">last revised in <\/span><\/b><span lang=\"EN-GB\">{<b>MM\/YYYY<\/b>}<\/span><span lang=\"EN-GB\">.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicine is available on the European\r Medicines Agency web site: <\/span><span lang=\"EN-GB\"><a href=\"http:\/\/www.ema.europa.eu\">http:\/\/www.ema.europa.eu<\/a><\/span><span lang=\"EN-GB\">.<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">------------------------------------------------------------------------------------------------------------------------<\/span><\/p> <p class=\"MsoNormal\" style=\"margin-right:-1.4pt;line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.4pt;margin-bottom:\r 0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal\"><b><span lang=\"EN-GB\">The following information is intended for healthcare professionals\r only:<\/span><\/b><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Use aseptic technique during the preparation of Alpivab to prevent\r microbial contamination. There is no preservative or antibacterial agent in the\r solution. Do not mix or co-infuse Alpivab with other medicines administered\r into a vein.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Follow the steps\r below in the provided order to prepare a diluted solution of Alpivab:<\/span><\/p> <p class=\"MsoListParagraphCxSpFirst\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Check the seal of each\r vial. Do not use if the seal opening is broken or missing.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inspect the Alpivab\r concentrate. It must be colourless and without particulate matter. <\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a patient receives\r 600 mg peramivir the required volume of Alpivab concentrate is 60 mL\r (3 vials of 20 mL each). In the case of a 300 mg peramivir dose,\r 30 mL (1\u00bd vials) of Alpivab concentrate is needed and for a\r 200 mg dose, only 20 mL (1 vial). Fractions of a vial may be\r needed for appropriate dose adjustments in children with a bodyweight of less\r than 50 kg.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Add the measured volume\r of Alpivab concentrate into the infusion container.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dilute the required dose\r of Alpivab concentrate in sodium chloride 9 mg\/mL (0.9 %) or\r 4.5 mg\/mL (0.45 %) solution for infusion, 5 % dextrose or Ringer\r lactate solution to a volume of 100 mL.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Administer the diluted\r solution via intravenous infusion over 15 to 30 minutes.<\/span><\/p> <p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:.25in;text-indent:-.25in;\r line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Once a diluted Alpivab\r solution has been prepared, administer immediately or store in a refrigerator\r (2 \u00b0C to 8 \u00b0C) for up to 24 hours. If refrigerated, allow the\r diluted Alpivab solution to reach room temperature, then administer\r immediately.<\/span><\/p> <p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0in;margin-right:0in;\r margin-bottom:0in;margin-left:.25in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Discard any unused\r diluted solution of Alpivab after 24 hours.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No special\r requirements for disposal.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Any unused medicinal product or waste material should be\r disposed of in accordance with local requirements.<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/div>","ID":"15201696-bd51-4bd4-896c-ae5a6f3618c7","Styles":"None","Classes":"['WordSection1']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       ","ParentId":"e5d30641-7d11-4f73-9e4a-c3a6312b9888"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f0544bbc-a91b-4dc8-a5ea-48c327d2aab7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e3821d39-34d5-4778-ab38-759a0ca38efe","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"6ae4af28-78b9-4183-ae23-13a0b0d6d711","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"fe031361-3a72-461d-ad51-0491557cc08b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"7f9770fa-44d6-4ad3-99a0-a2de418e5fa1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"822bbacf-3c96-4bab-8c9b-c688af40246e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"6c71067b-9f5f-44b0-86d7-c1e5bd0789a6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"af6626f1-f0a7-4e24-8ddf-c650fa2e3199","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"255a1f44-ea28-4750-bfda-52b359409833","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9c581055-9675-4460-afcf-292592a88d2c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"75f0fcb4-34f4-49fa-a6b7-09f734d6f22e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"a04e07d4-72c8-462c-8468-edc3eb4cd0f7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"fbe62148-61d7-44f4-bcbb-3bac0b9f198a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"7fb6236a-17ea-4e11-a155-45ea9eb85490","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d580afac-c7bb-4945-9604-74ede5548ee1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f9d359e1-69ca-4a84-9d77-04e41d976555","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"ba6dfb3b-d8e1-4511-8006-f61f768d21eb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"506ea710-0f7f-4cce-9916-1225e0a5a69a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"0bd0deed-9d4b-4899-82fb-977035854419","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f875fc66-b041-4828-8e99-0aadecd4b5ae","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"6dc1893d-9153-4025-aab9-e1d1204cbd6c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d7dd129a-cfeb-443d-b33e-b10ccf792896","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I<\/span><\/b><\/p>","ID":"76447bef-a73a-4834-962d-d03b13458678","Styles":"text-align:center;line-height:normal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":null,"Text":"ANNEX I","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e01978d0-d98e-44dc-88b4-094b8b2dd3eb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS<\/span><\/b><\/p>","ID":"35b544ec-7441-4922-af8d-d462d40771ba","Styles":"text-align:center;line-height:normal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"SUMMARY OF PRODUCT CHARACTERISTICS","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\r color:green'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span>","ID":"55b9f864-327f-4c7d-afba-1e4f60a1c9f7","Styles":"font-size:11.0pt;font-family:\"Times New Roman\",serif;\r\ncolor:green","Classes":"None","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":" ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<br clear=\"all\" style=\"page-break-before:always\"\/>","ID":"ad817041-d295-444f-9a5c-89a46f13b55a","Styles":"page-break-before:always","Classes":"None","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"55b9f864-327f-4c7d-afba-1e4f60a1c9f7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" id=\"Bild 1\" src=\"Alpivab%20EN%20PI%20clean_files\/image002.png\" width=\"22\"\/><\/span><span lang=\"EN-GB\">This medicinal product is subject\r to additional monitoring. This will allow quick identification of new safety\r information. Healthcare professionals are asked to report any suspected adverse\r reactions. See section 4.8 for how to report adverse reactions.<\/span><\/p>","ID":"d47eba3e-e350-4959-b510-9efdac96eb0e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"This medicinal product is subject\r to additional monitoring. This will allow quick identification of new safety\r information. Healthcare professionals are asked to report any suspected adverse\r reactions. See section 4.8 for how to report adverse reactions.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"998f1e10-9e17-4209-a8c6-1c9818f1a9e1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"db6bc05c-b5f4-4be6-a6ba-c2137de66460","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">1.       NAME OF <\/span><\/b><b><span lang=\"EN-GB\">THE\r MEDICINAL PRODUCT<\/span><\/b><\/p>","ID":"435620ff-0848-484f-bf76-6ec4b3d87408","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"1.       NAME OF THE\r MEDICINAL PRODUCT","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"898aef5f-f455-4261-80ac-c863c07a3133","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab 200 mg\r concentrate for solution for infusion<\/span><\/p>","ID":"c2b442de-17d1-42b0-b900-063bb6f27de1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Alpivab 200 mg\r concentrate for solution for infusion","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2c3a72af-86b9-40ee-aa21-dc173ec4bd67","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"20ed5ec2-653a-4e0d-989d-9ff0a8a2d956","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION<\/span><\/b><\/p>","ID":"e0cde079-7f0b-45e3-85ce-885e7872dab1","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"2.       QUALITATIVE AND QUANTITATIVE COMPOSITION","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"25ae47ec-a2fe-400a-827f-7c9ed207631e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 20 mL\r vial of concentrate contains 200 mg peramivir.<\/span><\/p>","ID":"07fcce9c-159e-417a-9237-bcc6b65b76c0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Each 20 mL\r vial of concentrate contains 200 mg peramivir.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 mL concentrate\r for solution for infusion contains 10 mg peramivir (anhydrous base).<\/span><\/p>","ID":"9c357b63-a106-4901-acd1-709d8ecdfc2d","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"1 mL concentrate\r for solution for infusion contains 10 mg peramivir (anhydrous base).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"92e40de5-7597-4762-9856-a093a9934798","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Excipients\r with known effect<\/span><\/u><\/p>","ID":"cca2a6fa-85a0-4835-931d-656be711277c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Excipients\r with known effect","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"fdfda5c0-12e9-4899-80a5-ccba122bf683","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each mL of\r concentrate contains 0.154 millimole (mmol) sodium, which is 3.54 mg\r of sodium.<\/span><\/p>","ID":"a5e49448-5ee5-40b4-b33e-ff063651fc68","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Each mL of\r concentrate contains 0.154 millimole (mmol) sodium, which is 3.54 mg\r of sodium.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"06ef63df-142a-434e-b6b2-2e6dec2c49cb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\r list of excipients, see section 6.1.<\/span><\/p>","ID":"69b6a690-0e4f-4f30-9cff-ed3e6376784c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"For the full\r list of excipients, see section 6.1.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"a567c7b5-49fc-4617-bd4c-19e343289983","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"a4eec6c0-f308-4103-897d-d8478f711569","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL FORM<\/span><\/b><\/p>","ID":"8ac930a1-b934-4d5f-98d9-6813ecc7a091","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"3.       PHARMACEUTICAL FORM","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b271d6ff-cb4d-4a64-8382-61e0197d9afb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Concentrate for\r solution for infusion.<\/span><\/p>","ID":"af1dde5a-99c5-425f-95a8-3a7044a8507f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Concentrate for\r solution for infusion.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clear,\r colourless, solution.<\/span><\/p>","ID":"cf9ff9d4-8502-43a2-8c61-9097c06bc519","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Clear,\r colourless, solution.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"03bd5aef-d1c7-44b2-b48f-944a36bda228","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"a4ea3e36-cf37-4f41-98cc-5dbbb15e4110","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       <\/span><\/b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS<\/span><\/b><\/p>","ID":"1b0f8df4-bb9f-4335-a9de-36a84435d40d","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"4.       CLINICAL PARTICULARS","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2d76d164-aa14-4592-a666-c2456ddd4498","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications<\/span><\/b><\/p>","ID":"d7f404f1-48ea-45ba-8ed1-9a1324bc4de0","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.1     Therapeutic indications","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"71f88b97-9949-423e-adf9-a9b6cc2157dd","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab is\r indicated for the treatment of uncomplicated influenza in adults and children\r from the age of 2 years (see sections 4.4 and 5.1).<\/span><\/p>","ID":"4da2fd65-60dc-48f1-8997-6b4659dae9e0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Alpivab is\r indicated for the treatment of uncomplicated influenza in adults and children\r from the age of 2 years (see sections 4.4 and 5.1).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"64065438-c48f-4420-9ab6-9d66bacaaf59","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">4.2     Posology\r and method of administration<\/span><\/b><\/p>","ID":"21527a76-44ee-4134-97e4-139f3ee559d1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.2     Posology\r and method of administration","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e3aab352-2a62-4977-a177-00b6264f1468","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Posology<\/span><\/u><\/p>","ID":"ce463028-dba2-4014-805a-14ccebec7ab7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Posology","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"02e459b0-239b-463d-85f5-93b7741c05ba","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">Alpivab should be administered as a single intravenous dose within\r 48 hours of the onset of symptoms of influenza.<\/span><\/p>","ID":"0d791097-07dc-4e87-bafe-691f6b77bbd4","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Alpivab should be administered as a single intravenous dose within\r 48 hours of the onset of symptoms of influenza.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p>","ID":"945c983c-2fb9-494d-bd5c-a127e8dd691c","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">The recommended single intravenous dose of peramivir depends on age\r and body weight as shown in Table 1.<\/span><\/p>","ID":"9f20fc5e-772e-4f38-a894-a2731f0c74dc","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The recommended single intravenous dose of peramivir depends on age\r and body weight as shown in Table 1.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p>","ID":"eca703b6-a4d1-4143-9ba9-29514e34f35a","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal\"><a name=\"_Hlk506883324\"><b><span lang=\"EN-GB\">Table 1: Peramivir\r dose based on age and body weight <\/span><\/b><\/a><\/p>","ID":"5db83618-d513-40b7-bdb4-3f3518a83c62","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Table 1: Peramivir\r dose based on age and body weight ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\"> <tr style=\"height:.4in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:.4in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><b><span lang=\"EN-GB\">Age and\r   body weight<\/span><\/b><\/p> <\/td> <td style=\"width:201.3pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.4in\" width=\"268\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><b><span lang=\"EN-GB\">Recommended\r   single dose<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Children aged\r   from 2 years and &lt;50 kg<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">12 mg\/kg<\/span><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Children aged\r   from 2 years and \u226550 kg body weight<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <tr style=\"height:.3in\"> <td style=\"width:3.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"336\"> <p class=\"MsoNormal\" style=\"line-height:14.0pt\"><span lang=\"EN-GB\">Adults and\r   adolescents (13 years and older)<\/span><\/p> <\/td> <td style=\"width:201.3pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:.3in\" width=\"268\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <\/table>","ID":"b0cedd9f-4b36-4a39-a6ed-945b0cf1fef2","Styles":"margin-left:-.25pt;border-collapse:collapse;border:none","Classes":"['MsoNormalTable']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"   Age and\r   body weight   Recommended\r   single dose     Children aged\r   from 2 years and <50 kg   12 mg\/kg     Children aged\r   from 2 years and \u226550 kg body weight   600 mg     Adults and\r   adolescents (13 years and older)   600 mg   ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b27cf494-190e-4a6c-b79b-ce216277e9dc","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly<\/span><\/i><\/p>","ID":"8875bbaa-9f49-44d8-98a7-6f98a3c72f37","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Elderly","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\r adjustment is required based on age (see sections 4.4 and 5.2).<\/span><\/p>","ID":"46bb7bb3-3496-4211-9992-09caf4ad3d26","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"No dose\r adjustment is required based on age (see sections 4.4 and 5.2).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e375c0a0-d921-4609-954a-416a5f24db2a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503790927\"><\/a><a name=\"_Hlk499654234\"><i><span lang=\"EN-GB\">Renal impairment<\/span><\/i><\/a><\/p>","ID":"0772aad1-c242-42a0-a23a-e727e22a979d","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Renal impairment","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503874094\"><span lang=\"EN-GB\">The dose should be reduced for adults and adolescents (13 years and\r older) with absolute glomerular filtration rate (GFR) below 50 mL\/min as\r shown in Table 2 (see sections 4.4 and 5.2). <\/span><\/a><\/p>","ID":"999779fa-5ced-4cd7-ac1f-0e8c07499938","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The dose should be reduced for adults and adolescents (13 years and\r older) with absolute glomerular filtration rate (GFR) below 50 mL\/min as\r shown in Table 2 (see sections 4.4 and 5.2). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"49930a75-d684-4b10-aa43-25d2502c7c0b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoCaption\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\r margin-left:.6in;text-indent:-.6in;line-height:normal\"><a name=\"_Ref499728619\"><span style=\"font-size:11.0pt\">Table<\/span><\/a><span style=\"font-size:11.0pt\"> 2: Peramivir\r dose for adults and adolescents (from 13 years and 50 kg) based on absolute GFR<\/span><\/p>","ID":"80be2b7d-6f28-494d-ba7f-3a38c444d45e","Styles":"margin-top:0in;margin-right:0in;margin-bottom:0in;\r\nmargin-left:.6in;text-indent:-.6in;line-height:normal","Classes":"['MsoCaption']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Table 2: Peramivir\r dose for adults and adolescents (from 13 years and 50 kg) based on absolute GFR","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.25pt;border-collapse:collapse;border:none\"> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><b><span lang=\"EN-GB\">Absolute Glomerular Filtration Rate (GFR)*<\/span><\/b><\/p> <\/td> <td style=\"width:237.3pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><b><span lang=\"EN-GB\">Recommended single dose<\/span><\/b><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">\u226550<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">600 mg<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">30 to 49<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">300 mg<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:3.0in;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"288\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">10 to 29<\/span><\/p> <\/td> <td style=\"width:237.3pt;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"316\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:14.0pt\"><span lang=\"EN-GB\">200 mg<\/span><\/p> <\/td> <\/tr> <\/table>","ID":"22835c42-4861-4b25-8f17-9126c4760132","Styles":"margin-left:-.25pt;border-collapse:collapse;border:none","Classes":"['MsoNormalTable']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"   Absolute Glomerular Filtration Rate (GFR)*   Recommended single dose     \u226550   600 mg     30 to 49   300 mg     10 to 29   200 mg   ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">*Absolute GFR not adjusted for body surface\r area<\/span><\/p>","ID":"35ea1855-4cc1-4097-b0f1-7f037a893866","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"*Absolute GFR not adjusted for body surface\r area","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"3a0671c0-d2ff-428e-b4f4-2a9ad3dfe8bc","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In adults and adolescents (from 13 years and 50 kg) with chronic\r renal impairment maintained on haemodialysis, peramivir should be administered\r after dialysis at a dose adjusted for renal function (Table 2).<\/span><\/p>","ID":"113767e1-93d4-48ae-9900-73f74311ed3a","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In adults and adolescents (from 13 years and 50 kg) with chronic\r renal impairment maintained on haemodialysis, peramivir should be administered\r after dialysis at a dose adjusted for renal function (Table 2).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"89d4adb1-8bfe-4b10-9b5c-16d46d6c60ec","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"><span style=\"font-size:11.0pt\">There are insufficient clinical data available in\r children and adolescents aged less than 13 years or with body weight less than\r 50 kg with renal impairment to be able to make any dosing recommendation.<\/span><\/p>","ID":"916d490f-ff82-4823-8e44-4c82787db9fc","Styles":"text-align:left","Classes":"['ResponseText']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"There are insufficient clinical data available in\r children and adolescents aged less than 13 years or with body weight less than\r 50 kg with renal impairment to be able to make any dosing recommendation.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"> <\/p>","ID":"41e58bdf-8664-4cd6-a6dc-bcdbe11663d3","Styles":"text-align:left","Classes":"['ResponseText']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":" ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p align=\"left\" class=\"ResponseText\" style=\"text-align:left\"><i><span style=\"font-size:11.0pt\">Hepatic impairment<\/span><\/i><\/p>","ID":"3b7bfaad-ef22-4307-9e52-4aaa21bb0b2c","Styles":"text-align:left","Classes":"['ResponseText']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Hepatic impairment","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\r adjustment is required in patients with hepatic impairment (see section 5.2).<\/span><\/p>","ID":"9972f9ac-3420-4e4f-a068-b7533cabc05c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"No dose\r adjustment is required in patients with hepatic impairment (see section 5.2).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"0c547e59-6bcd-41fa-8087-f99ed8cc65bf","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk500172668\"><i><span lang=\"EN-GB\">Paediatric population<\/span><\/i><\/a><\/p>","ID":"85f85db9-9002-4957-9e0a-31712559d380","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Paediatric population","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of peramivir in children aged under 2 years\r has not yet been established. No data are available.<\/span><\/p>","ID":"4a3fbb71-ab53-48fa-a08b-b6c82c9701fb","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The safety and efficacy of peramivir in children aged under 2 years\r has not yet been established. No data are available.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p>","ID":"b1985bf7-17d4-4168-beac-fd5c9deb45c1","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Method of\r administration<\/span><\/u><\/p>","ID":"295971b6-d12d-470b-9dc6-e27624de6f15","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Method of\r administration","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9b42756f-e25f-426b-bdb2-3736e8ce9423","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Alpivab is administered\r via intravenous infusion for 15 to 30 minutes. <\/span><\/p>","ID":"21ffe9ff-7296-49bc-b559-87a634f725ec","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Alpivab is administered\r via intravenous infusion for 15 to 30 minutes. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before\r administration, see section 6.6.<\/span><\/p>","ID":"1da9e3a2-20e2-44d8-b371-8718930749ad","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"For instructions on dilution of the medicinal product before\r administration, see section 6.6.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p>","ID":"02b4727c-888e-466a-a17d-cd73fca666bf","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.3     Contraindications<\/span><\/b><\/p>","ID":"17fc3932-4718-4413-8993-bf4a1e78332c","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.3     Contraindications","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b39bf5b3-5fa3-4243-8389-443ecc92f73f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\r to the active substance or to any of the excipients listed in section 6.1.<\/span><\/p>","ID":"7eb068c0-ab04-4b3e-b0d4-7596d03490c3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Hypersensitivity\r to the active substance or to any of the excipients listed in section 6.1.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9a67c9bf-5d6b-486f-bd43-758150ea47d8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use<\/span><\/b><\/p>","ID":"4b3c03ea-a723-45c1-9fdf-987843bc7612","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.4     Special warnings and precautions for use","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"43c6078a-3e01-4eb6-98ef-58adcf5415ad","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Serious hypersensitivity<\/span><\/u><u><span lang=\"EN-GB\"> r<\/span><\/u><u><span lang=\"EN-GB\">eactions<\/span><\/u><\/p>","ID":"530b0893-c505-4d49-808d-e3052c5e0928","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Serious hypersensitivity reactions","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"65d90328-ccce-4c52-b971-d14fcef00392","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Anaphylactic\r reactions and serious skin reactions (including erythema multiforme, toxic\r epidermal necrolysis and Stevens-Johnson syndrome) have been reported with peramivir\r (see section 4.8). If any hypersensitivity reaction occurs during infusion of peramivir,\r the infusion must be stopped immediately and appropriate management should be\r instituted.<\/span><\/p>","ID":"c3434fad-6144-45e5-92a5-ab7597eb5fa6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Anaphylactic\r reactions and serious skin reactions (including erythema multiforme, toxic\r epidermal necrolysis and Stevens-Johnson syndrome) have been reported with peramivir\r (see section 4.8). If any hypersensitivity reaction occurs during infusion of peramivir,\r the infusion must be stopped immediately and appropriate management should be\r instituted.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"1152601e-eccd-4bb0-80c8-319d81cc9167","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Neuropsychiatric\r events<\/span><\/u><\/p>","ID":"c430ec68-d963-4346-b949-ab4a0e45e43f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Neuropsychiatric\r events","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"63c386a6-712d-4965-a181-7e91ca37153b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Delirium,\r hallucinations and abnormal behaviour have been reported in patients with\r influenza who were receiving peramivir. These events were reported primarily\r among paediatric patients and often had an abrupt onset and rapid resolution.\r The contribution of peramivir to these events has not been established.\r Patients with influenza should be closely monitored for signs of abnormal behaviour.\r <\/span><\/p>","ID":"e480fd78-54ea-4c61-937d-fab4b6255e2f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Delirium,\r hallucinations and abnormal behaviour have been reported in patients with\r influenza who were receiving peramivir. These events were reported primarily\r among paediatric patients and often had an abrupt onset and rapid resolution.\r The contribution of peramivir to these events has not been established.\r Patients with influenza should be closely monitored for signs of abnormal behaviour.\r ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"8f28cd0a-a233-4a38-b3be-50d72eba12d4","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\r normal\">Reduced renal function<\/span><\/u><\/p>","ID":"988df313-e900-4d48-94c0-5e4b2d2b8d21","Styles":"None","Classes":"['MsoBodyText']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Reduced renal function","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoBodyText\"><s><u><span lang=\"EN-GB\" style=\"color:red;font-style:normal\"><\/span><\/u><\/s><\/p>","ID":"bf44d2c0-c0b8-4035-8add-d0444bac84fc","Styles":"None","Classes":"['MsoBodyText']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Acute\r renal failure, renal failure, pre-renal failure, renal disorder, anuria,\r nephritis, and increased blood creatinine have been reported in patients with\r influenza who were receiving peramivir. Most of the cases occurred in elderly\r patients with comorbidities and multiple concomitant medicinal products. The\r contribution of peramivir to these events has not been established. Patients\r with influenza and already existing diseases should be closely monitored for\r renal function.<\/span><\/p>","ID":"37b1a34a-244a-4434-ae56-5392fcc4a549","Styles":"None","Classes":"['MsoBodyText']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Acute\r renal failure, renal failure, pre-renal failure, renal disorder, anuria,\r nephritis, and increased blood creatinine have been reported in patients with\r influenza who were receiving peramivir. Most of the cases occurred in elderly\r patients with comorbidities and multiple concomitant medicinal products. The\r contribution of peramivir to these events has not been established. Patients\r with influenza and already existing diseases should be closely monitored for\r renal function.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"3c18cc8b-6432-4983-97b8-47863e1b40c0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:14.0pt\"><u><span lang=\"EN-GB\">Limitations of the clinical data<\/span><\/u><\/p>","ID":"4b8e8fb8-2cdb-4279-b4bd-011c324f8819","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:14.0pt","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Limitations of the clinical data","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:14.0pt\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"b4f1b05c-5325-462c-b109-44a9a8724b95","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:14.0pt","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><span lang=\"EN-GB\">The efficacy of peramivir as a single dose treatment for\r uncomplicated influenza was demonstrated in a single placebo-controlled study\r conducted in 300 adult patients in Japan during the 2007\/2008 influenza\r season. The recommended 600 mg single intravenous dose resulted in shortening\r of the median time to alleviation of symptoms by 21 hours (see section 5.1).<\/span><\/p>","ID":"e1bfd2ef-3e8d-40f6-a7b9-eca63e16ba7a","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The efficacy of peramivir as a single dose treatment for\r uncomplicated influenza was demonstrated in a single placebo-controlled study\r conducted in 300 adult patients in Japan during the 2007\/2008 influenza\r season. The recommended 600 mg single intravenous dose resulted in shortening\r of the median time to alleviation of symptoms by 21 hours (see section 5.1).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph\"><\/p>","ID":"4f2c0072-0c84-4983-896d-1d09ba0fd35c","Styles":"text-align:justify;text-justify:inter-ideograph","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Available data\r do not support a conclusion that peramivir is effective in patients with\r influenza B or in patients with complicated influenza.<\/span><\/p>","ID":"34eb0e35-7774-48a7-b074-a27390b3d4eb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Available data\r do not support a conclusion that peramivir is effective in patients with\r influenza B or in patients with complicated influenza.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"7f8a20ef-924b-4db2-8498-070e03158b0d","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><u><span lang=\"EN-GB\">Resistance to peramivir<\/span><\/u><\/p>","ID":"6adb57d7-7822-491b-b041-5ac8238de527","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Resistance to peramivir","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"bc303091-d791-49f6-88c2-369bd83846db","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">Influenza A\/H1N1 viruses that contain the\r H275Y mutation have reduced susceptibility to peramivir and oseltamivir. In a\r clinical trial, no statistically significant clinical benefit could be\r demonstrated for peramivir over placebo in patients infected with the A\/H1N1\r virus containing the H275Y mutation. Available information on influenza drug\r susceptibility should be taken into account when deciding whether to use peramivir\r (see section 5.1). <\/span><\/p>","ID":"20fa66e5-3e38-403e-8c62-d0f350fea993","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Influenza A\/H1N1 viruses that contain the\r H275Y mutation have reduced susceptibility to peramivir and oseltamivir. In a\r clinical trial, no statistically significant clinical benefit could be\r demonstrated for peramivir over placebo in patients infected with the A\/H1N1\r virus containing the H275Y mutation. Available information on influenza drug\r susceptibility should be taken into account when deciding whether to use peramivir\r (see section 5.1). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><\/p>","ID":"1e12cae9-7dd7-49ed-9342-75520b9d4f5f","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Risk of bacterial\r infections<\/span><\/u><\/p>","ID":"49420946-b7c3-4ce9-96e9-737e5978ed54","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Risk of bacterial\r infections","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"6a924a82-7e06-4df5-9eb7-dc8824dc7497","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\r evidence for efficacy of peramivir in any illness caused by agents other than\r influenza viruses. Serious bacterial infections may begin with influenza-like\r symptoms or may coexist with or occur as complications during the course of\r influenza. Peramivir has not been shown to prevent such complications. <\/span><\/p>","ID":"c6c61d14-e5b2-458a-9b90-f8d94670abb6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"There is no\r evidence for efficacy of peramivir in any illness caused by agents other than\r influenza viruses. Serious bacterial infections may begin with influenza-like\r symptoms or may coexist with or occur as complications during the course of\r influenza. Peramivir has not been shown to prevent such complications. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p>","ID":"54d79ded-0381-4dc4-8a55-56a530bd1f3f","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Excipients<\/span><\/u><\/p>","ID":"f01a262a-462c-49af-9381-a8cd473c8425","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Excipients","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"bbc99fa3-0124-41b9-83de-7ec3585d20d1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">This medicinal product contains 212.4 mg sodium per 3 vials,\r equivalent to 10.6% of the World Health Organization (WHO) recommended maximum\r daily intake of 2 g sodium for an adult.<\/span><\/p>","ID":"ac886545-83c9-427a-a819-1613d10692ae","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"This medicinal product contains 212.4 mg sodium per 3 vials,\r equivalent to 10.6% of the World Health Organization (WHO) recommended maximum\r daily intake of 2 g sodium for an adult.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"c2f6244e-c51b-4284-96cb-344f21c57471","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products\r and other forms of interaction<\/span><\/b><\/p>","ID":"c4ec3f1f-2d13-4407-8dc9-021635ec62f0","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.5     Interaction with other medicinal products\r and other forms of interaction","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2fc14d48-4832-4028-8708-0c8e6599d92d","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The potential\r for interactions of peramivir with other medicines is low, based on the known\r elimination pathway of peramivir. <\/span><\/p>","ID":"a3678590-6298-48ca-9d21-c3e346510dac","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The potential\r for interactions of peramivir with other medicines is low, based on the known\r elimination pathway of peramivir. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b683dad4-fd75-4b9e-8a6a-489d3cdbb59c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">Live attenuated influenza vaccines are not\r recommended to be used until 48 hours following Alpivab administrationdue to a theoretical risk that peramivir could reduce\r the immunogenicity of the vaccine.<\/span><\/p>","ID":"ae928e68-aeb9-4e0e-8a12-574d38e49036","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Live attenuated influenza vaccines are not\r recommended to be used until 48 hours following Alpivab administrationdue to a theoretical risk that peramivir could reduce\r the immunogenicity of the vaccine.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"734f6166-ecce-4f3e-9332-8d6b0902e4f5","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.6     <\/span><\/b><b><span lang=\"EN-GB\">Fertility, p<\/span><\/b><b><span lang=\"EN-GB\">regnancy and lactation<\/span><\/b><\/p>","ID":"f2819857-1da4-402e-8ff6-f2a56e320a7a","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.6     Fertility, pregnancy and lactation","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"02cb6c8c-2b16-4c5a-a785-b7c91e5c8a27","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Pregnancy<\/span><\/u><\/p>","ID":"588dbaf0-d20b-4cad-939a-6a45de6cbd94","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Pregnancy","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"d8e3b2b0-900c-4c7e-90db-c8eb6ac3354a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no or\r limited amount of data (less than 300 pregnancies outcomes) from the use of\r peramivir in pregnant women. <\/span><\/p>","ID":"b4600184-2abb-400a-b387-bac08c2bc63f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"There are no or\r limited amount of data (less than 300 pregnancies outcomes) from the use of\r peramivir in pregnant women. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"36e116f5-231a-44c0-8ee0-b5e1419374b7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Animal studies\r do not indicate direct or indirect harmful effects with respect to reproductive\r toxicity (see section 5.3). <\/span><\/p>","ID":"98b24797-4453-4462-b4d9-aedcf508be16","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Animal studies\r do not indicate direct or indirect harmful effects with respect to reproductive\r toxicity (see section 5.3). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"620787bf-fc1a-44b9-8f96-1388e28b5c0f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">As a\r precautionary measure, it is preferable to avoid the use of peramivir during\r pregnancy.<\/span><\/p>","ID":"ebf385bc-b127-4bfa-b3c1-04a282bbba38","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"As a\r precautionary measure, it is preferable to avoid the use of peramivir during\r pregnancy.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"bdc8fbba-114d-41e5-9828-c150083ab6a4","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk506829124\"><u><span lang=\"EN-GB\">Breast-feeding<\/span><\/u><\/a><\/p>","ID":"8959e4f0-1e84-4b83-8576-a8e7fca61a3a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Breast-feeding","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"ec2b01de-66be-4b76-96c2-bcf810a2c8ea","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><span style=\"color:black\">Available\r pharmacodynamic\/toxicological data in animals have shown excretion of peramivir\r in milk (see section 5.3).<\/span><\/p>","ID":"e61a70eb-bb1a-4a0a-ac6d-a16697badcdd","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Available\r pharmacodynamic\/toxicological data in animals have shown excretion of peramivir\r in milk (see section 5.3).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p>","ID":"fc39ca67-40ba-4df7-824f-2135682a1bc4","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">A risk\r to the newborns\/infants cannot be excluded.<\/span><\/p>","ID":"233345c6-304d-41a5-8943-151d0f447513","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"A risk\r to the newborns\/infants cannot be excluded.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"af089fa9-ebd0-4a78-a8c3-3ff2a31e4972","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must\r be made whether to discontinue breast-feeding or to discontinue\/abstain from peramivir\r therapy taking into account the benefit of breast-feeding for the child and the\r benefit of therapy for the woman.<\/span><\/p>","ID":"e5914acb-fc8d-45ed-890a-6fe9189a2b48","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"A decision must\r be made whether to discontinue breast-feeding or to discontinue\/abstain from peramivir\r therapy taking into account the benefit of breast-feeding for the child and the\r benefit of therapy for the woman.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"faa001ef-1eb7-42e2-a4b2-b27ae02dec45","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Fertility<\/span><\/u><\/p>","ID":"9eaed0ed-1df6-4d84-8504-e9574d5ac9cf","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Fertility","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"fc7f0c24-a8cc-4393-af67-156954b6391e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No human data on\r the effect of peramivir on fertility are available. Peramivir had no effects on\r mating or fertility in animal studies (see section 5.3). <\/span><\/p>","ID":"bcc71832-5002-4c57-85e7-585e919306b8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"No human data on\r the effect of peramivir on fertility are available. Peramivir had no effects on\r mating or fertility in animal studies (see section 5.3). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"8980deb5-c014-4a01-9380-70f875921d0d","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use\r machines<\/span><\/b><\/p>","ID":"12ecca30-83e6-452f-980c-8d80a304a497","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.7     Effects on ability to drive and use\r machines","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9a6c86ff-26d6-41c3-8949-2d9277506551","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir has no\r or negligible influence on the ability to drive and use machines.<\/span><\/p>","ID":"2d74b915-503a-4619-9564-b335e03447cc","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir has no\r or negligible influence on the ability to drive and use machines.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9e86554d-afe3-437c-937e-a631d94c2883","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects<\/span><\/b><\/p>","ID":"5599890c-bebf-48bc-8b71-be11ebe8025b","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.8     Undesirable effects","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;page-break-after:avoid;text-autospace:none\"><\/p>","ID":"6a400638-c4d7-43c7-9090-39c3ad0928eb","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal;page-break-after:avoid;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Summary of the safety profile<\/span><\/u><\/p>","ID":"4af1f2a0-1c21-4dda-82e1-da48e076e7b5","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Summary of the safety profile","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"2b4cfc8d-243c-4a93-aa7c-631605473917","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most important\r serious adverse reactions associated with permivir in patients are anaphylaxis\r and <\/span><span lang=\"EN-GB\">skin reactions, including erythema multiforme and\r Stevens-Johnson Syndrome. <\/span><\/p>","ID":"d7d76ff1-8873-4361-b274-d827f255e115","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The most important\r serious adverse reactions associated with permivir in patients are anaphylaxis\r and skin reactions, including erythema multiforme and\r Stevens-Johnson Syndrome. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">Among 467 adult\r subjects with uncomplicated influenza who received a single intravenous dose of\r <\/span><span lang=\"EN-GB\">peramivir<\/span><span lang=\"EN-GB\"> 600 mg in\r clinical trials, the most commonly observed adverse reactions were neutrophil\r count decreased (3.2 %) and nausea (2.4 %). <\/span><\/p>","ID":"e2d5be68-6eca-42ce-8d75-c9b3fd4fd810","Styles":"page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Among 467 adult\r subjects with uncomplicated influenza who received a single intravenous dose of\r peramivir 600 mg in\r clinical trials, the most commonly observed adverse reactions were neutrophil\r count decreased (3.2 %) and nausea (2.4 %). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><\/p>","ID":"0ef70b2f-f592-4412-b4a3-edcfce1f2e05","Styles":"page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Tabulated list of\r adverse reactions<\/span><\/u><\/p>","ID":"65c95d8b-45ba-4d6d-aa49-d2ed84b8d817","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Tabulated list of\r adverse reactions","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"ac31879b-ec83-4b95-9c7c-541f6c69ad84","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Frequencies are\r defined as very common (\u22651\/10), common (\u22651\/100 to &lt;1\/10),\r uncommon (\u22651\/1000 to &lt;1\/100), rare (\u22651\/10,000 to &lt;1\/1000),\r very rare (&lt;1\/10,000).<\/span><\/p>","ID":"83f75e05-c8b1-4e14-991f-dac95cc05a9d","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Frequencies are\r defined as very common (\u22651\/10), common (\u22651\/100 to <1\/10),\r uncommon (\u22651\/1000 to <1\/100), rare (\u22651\/10,000 to <1\/1000),\r very rare (<1\/10,000).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p>","ID":"cf18b017-03b5-470b-84c4-6f45cb838fb9","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><a name=\"_Hlk498529576\"><b><span lang=\"EN-GB\">Table 3: <span style=\"color:black;background:white\">Adverse\r reactions in studies investigating peramivir for treatment of uncomplicated\r influenza in adults <\/span><\/span><\/b><\/a><\/p>","ID":"2513ec23-d85f-45b8-8cde-325b0ed929a5","Styles":"page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Table 3: Adverse\r reactions in studies investigating peramivir for treatment of uncomplicated\r influenza in adults ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-.5pt;border-collapse:collapse;border:none\" width=\"648\"> <thead> <tr style=\"height:28.5pt\"> <td rowspan=\"2\" style=\"width:1.5in;border:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:28.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">System\r    Organ Class (SOC)<\/span><\/b><\/p> <\/td> <td colspan=\"4\" style=\"width:5.25in;border:solid windowtext 1.0pt;\r    border-left:none;padding:0in 5.4pt 0in 5.4pt;height:28.5pt\" width=\"504\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Adverse Reaction According to Frequency*<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:15.75pt\"> <td style=\"width:1.25in;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Common<\/span><\/b><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Uncommon<\/span><\/b><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rare<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r    border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r    padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Unknown<\/span><\/b><\/p> <\/td> <\/tr> <\/thead> <tr style=\"height:29.25pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Blood and\r   lymphatic system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">neutrophil\r   count decreased<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:29.25pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:29.25pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Immune\r   system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">anaphylactic\r   reaction*, anaphylactic shock*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:137.2pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Metabolism\r   and nutrition disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">blood lactate\r   dehydrogenase increased<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">decreased\r   appetite, blood albumin decreased, blood chloride increased, blood glucose\r   decreased, blood lactate dehydrogenase decreased, blood potassium increased,\r   blood sodium increased, blood uric acid increased, protein total increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:137.2pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:137.2pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Psychiatric\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">insomnia<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">abnormal\r   behaviour*, delirium*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Nervous\r   system disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">hypoaesthesia,\r   paraesthesia<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:15.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Eye\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vision blurred<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:30.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Cardiac\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">electrocardiogram\r   QT prolonged<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:30.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:30.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:40.0pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">nausea,\r   vomiting<\/span><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">abdominal pain\r   upper, abdominal discomfort, gastritis<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:40.0pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:40.0pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:75.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hepatobiliary\r   disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">increased\r   gamma-glutamyltransferase<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:75.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:75.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">liver\r   disorder*, alanine aminotransferase increased*, aspartate aminotransferase\r   increased* <\/span><\/p> <\/td> <\/tr> <tr style=\"height:45.75pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\r   subcutaneous tissue disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">dermatitis,\r   drug eruption, eczema, urticaria<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:45.75pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">erythema\r   multiforme<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:45.75pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">dermatitis\r   exfoliative*, Stevens-Johnson syndrome*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:43.5pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\r   and connective tissue disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">arthralgia,\r   blood creatine phosphokinase increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:43.5pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <tr style=\"height:63.8pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Renal and\r   urinary disorders<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">blood urea\r   increased, blood present in urine, urobilin present in urine, blood\r   creatinine increased, urine ketone body increased<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:63.8pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:63.8pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">acute kidney\r   injury*, renal impairment*<\/span><\/p> <\/td> <\/tr> <tr style=\"height:43.5pt\"> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-top:\r   none;padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"144\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\r   disorders and administration site conditions<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:135.0pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"180\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">chest\r   discomfort, fatigue<\/span><\/p> <\/td> <td style=\"width:63.0pt;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:43.5pt\" width=\"84\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:43.5pt\" width=\"120\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><\/p> <\/td> <\/tr> <\/table>","ID":"5b53b7ef-6ba5-4c2b-bbd7-edc4e1d130ff","Styles":"margin-left:-.5pt;border-collapse:collapse;border:none","Classes":"['MsoNormalTable']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"    System\r    Organ Class (SOC)   Adverse Reaction According to Frequency*     Common   Uncommon   Rare   Unknown      Blood and\r   lymphatic system disorders   neutrophil\r   count decreased              Immune\r   system disorders            anaphylactic\r   reaction*, anaphylactic shock*     Metabolism\r   and nutrition disorders   blood lactate\r   dehydrogenase increased   decreased\r   appetite, blood albumin decreased, blood chloride increased, blood glucose\r   decreased, blood lactate dehydrogenase decreased, blood potassium increased,\r   blood sodium increased, blood uric acid increased, protein total increased           Psychiatric\r   disorders      insomnia      abnormal\r   behaviour*, delirium*     Nervous\r   system disorders      hypoaesthesia,\r   paraesthesia           Eye\r   disorders      vision blurred           Cardiac\r   disorders      electrocardiogram\r   QT prolonged           Gastrointestinal\r   disorders   nausea,\r   vomiting   abdominal pain\r   upper, abdominal discomfort, gastritis           Hepatobiliary\r   disorders      increased\r   gamma-glutamyltransferase      liver\r   disorder*, alanine aminotransferase increased*, aspartate aminotransferase\r   increased*      Skin and\r   subcutaneous tissue disorders      dermatitis,\r   drug eruption, eczema, urticaria   erythema\r   multiforme   dermatitis\r   exfoliative*, Stevens-Johnson syndrome*     Musculoskeletal\r   and connective tissue disorders      arthralgia,\r   blood creatine phosphokinase increased           Renal and\r   urinary disorders      blood urea\r   increased, blood present in urine, urobilin present in urine, blood\r   creatinine increased, urine ketone body increased      acute kidney\r   injury*, renal impairment*     General\r   disorders and administration site conditions      chest\r   discomfort, fatigue         ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"TableTextFootnote\"><span style=\"color:windowtext\">*These events\r reported from post-authorization use occurred with different dosage and dosing\r schedule to that described in the SmPC.<\/span><\/p>","ID":"a59794b8-fc8b-400c-90a1-42cc84e5371f","Styles":"None","Classes":"['TableTextFootnote']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"*These events\r reported from post-authorization use occurred with different dosage and dosing\r schedule to that described in the SmPC.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r text-autospace:none\"><\/p>","ID":"8c14fac8-559b-422d-9b6e-77a0819356e7","Styles":"text-align:justify;text-justify:inter-ideograph;\r\ntext-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">Paediatrics<\/span><\/i><\/p>","ID":"8a742808-197e-44fd-bcf0-a9fcbbae2775","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Paediatrics","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">In\r paediatric subjects (age 2 to 17 years) with uncomplicated influenza enrolled\r in a clinical trial, the safety profile of peramivir was similar to that\r reported in adults. Common a<\/span><span lang=\"EN-GB\">dverse reactions not\r reported in adults were injection site rash, pyrexia, tympanic membrane\r hyperaemia, psychomotor hyperactivity, and pruritus. <\/span><\/p>","ID":"4f5dea24-6751-4bf3-8437-4a93297eccfe","Styles":"page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In\r paediatric subjects (age 2 to 17 years) with uncomplicated influenza enrolled\r in a clinical trial, the safety profile of peramivir was similar to that\r reported in adults. Common adverse reactions not\r reported in adults were injection site rash, pyrexia, tympanic membrane\r hyperaemia, psychomotor hyperactivity, and pruritus. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p>","ID":"06a8dab2-6c02-4bfe-ba2e-37237befd2d6","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions<\/span><\/u><\/p>","ID":"2db89d09-181a-46d0-a63d-04e980191801","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Reporting of suspected adverse reactions","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"0432131a-cf5d-4038-9918-394c720c7d75","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\r medicinal product is important. It allows continued monitoring of the\r benefit\/risk balance of the medicinal product. Healthcare professionals are\r asked to report any suspected adverse reactions via the national reporting\r system listed in <\/span><span lang=\"EN-GB\"><a href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Template_or_form\/2013\/03\/WC500139752.doc\">Appendix\r V<\/a><\/span><span lang=\"EN-GB\">.<\/span><\/p>","ID":"fd5b64ed-c54a-4f08-b1d4-81965cac92cb","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Reporting suspected adverse reactions after authorisation of the\r medicinal product is important. It allows continued monitoring of the\r benefit\/risk balance of the medicinal product. Healthcare professionals are\r asked to report any suspected adverse reactions via the national reporting\r system listed in Appendix\r V.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"1d6e402e-ce94-496b-8057-1958748e77e2","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose<\/span><\/b><\/p>","ID":"8c2746b0-2252-4f7c-82b3-8593e98dd361","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"4.9     Overdose","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\r none\"><\/p>","ID":"e9f7b7dc-e69b-4c91-86c4-99ac5d7007cd","Styles":"line-height:normal;page-break-after:avoid;text-autospace:\r\nnone","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\r none\"><span lang=\"EN-GB\">There is no experience of acute overdose with peramivir\r in humans. Treatment of an overdose should consist of general supportive\r measures including monitoring of vital signs and observation of the clinical\r status of the patient. <\/span><\/p>","ID":"adbdbf2d-70da-4ed2-a343-a158d9671f03","Styles":"line-height:normal;page-break-after:avoid;text-autospace:\r\nnone","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"There is no experience of acute overdose with peramivir\r in humans. Treatment of an overdose should consist of general supportive\r measures including monitoring of vital signs and observation of the clinical\r status of the patient. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p>","ID":"a7bfd2ed-5a98-4756-aadc-0f2589f8826e","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Peramivir is cleared by renal excretion and can be cleared by haemodialysis.\r There is no specific antidote to treat an overdose of this medicine.<\/span><\/p>","ID":"d6b12b72-3ba4-419b-9a92-ea45bb239e1e","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir is cleared by renal excretion and can be cleared by haemodialysis.\r There is no specific antidote to treat an overdose of this medicine.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b1eff83a-7fbd-4de1-bca2-b29bcc29e61b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"8efd5fc0-e38a-4859-88ba-ee53f2ebb8eb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL\r PROPERTIES<\/span><\/b><\/p>","ID":"d3d5acf0-bca2-43b2-bab9-86c7d6b8572a","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"5.       PHARMACOLOGICAL\r PROPERTIES","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"c9b339b1-5db6-457d-be74-dc6eeb3a9f29","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic\r properties<\/span><\/b><\/p>","ID":"d1839840-9cd5-4f4b-b1a7-e17efe29ec07","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"5.1     Pharmacodynamic\r properties","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"551d42db-f839-4d7c-ae76-07120e8e3cd8","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Antivirals for systemic use,\r neuraminidase inhibitors ATC code<\/span><b><span lang=\"EN-GB\">: <\/span><\/b><span lang=\"EN-GB\">J05AH03<\/span><\/p>","ID":"696258bc-bee0-46bd-a10a-41d17824555c","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Pharmacotherapeutic group: Antivirals for systemic use,\r neuraminidase inhibitors ATC code: J05AH03","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"6d60dedd-2152-4906-90dd-7efa1cf74f47","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">Mechanism of action<\/span><\/u><\/p>","ID":"12e9197a-b618-4ff5-9481-b0d290d70985","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Mechanism of action","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><\/p>","ID":"10647496-4fc7-4257-9343-63580368b631","Styles":"line-height:normal;text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Peramivir is an inhibitor of influenza virus neuraminidase, an\r enzyme that releases viral particles from the plasma membrane of infected cells\r and is also important for viral entry into uninfected cells, which causes further\r spread of infectious virus in the body.<\/span><\/p>","ID":"758c2575-ae62-4f3e-ade1-2300dcf9156a","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir is an inhibitor of influenza virus neuraminidase, an\r enzyme that releases viral particles from the plasma membrane of infected cells\r and is also important for viral entry into uninfected cells, which causes further\r spread of infectious virus in the body.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p>","ID":"ae0b7f4b-1ce9-426b-9e8c-66f115b676fd","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><u><span lang=\"EN-GB\">In-vitro<\/span><\/u><\/i><u><span lang=\"EN-GB\"> activity <\/span><\/u><\/p>","ID":"ae5b048e-80df-4ff7-8ab1-48bf69139ad7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"In-vitro activity ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"a191dbbc-fb1c-4001-850b-3b454f9cca3a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Neuraminidase\r inhibition occurred at very low peramivir concentrations <i>in-vitro<\/i>, with\r median inhibitory concentration 50% (IC<sub>50<\/sub>) values of 0.13 nanomolar\r (nM) to 0.99 nM against influenza A and B strains.<\/span><\/p>","ID":"483a2ca0-074d-4923-80cc-c1936614daec","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Neuraminidase\r inhibition occurred at very low peramivir concentrations in-vitro, with\r median inhibitory concentration 50% (IC50) values of 0.13 nanomolar\r (nM) to 0.99 nM against influenza A and B strains.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"3d4995fd-d131-4d20-8802-92271f941abb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><a name=\"_Hlk503779250\"><i><span lang=\"EN-GB\">Resistance<\/span><\/i><\/a><\/p>","ID":"c94fe3a1-7473-4d47-8dc9-4c6fb18a3ed3","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Resistance","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">In a clinical\r trial in which 245 subjects <a name=\"_Hlk500240383\">were infected at baseline\r with influenza<\/a> A\/H1N1 containing the H275Y mutation, the median baseline IC<sub>50<\/sub>\r values for peramivir, oseltamivir and zanamivir were 51.0 nM, 487.6 nM and 0.95\r nM, respectively. <\/span><\/p>","ID":"209e6a03-0429-422c-a020-5b65c67c2881","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In a clinical\r trial in which 245 subjects were infected at baseline\r with influenza A\/H1N1 containing the H275Y mutation, the median baseline IC50\r values for peramivir, oseltamivir and zanamivir were 51.0 nM, 487.6 nM and 0.95\r nM, respectively. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><\/p>","ID":"8991f947-1152-4cf9-8d14-bc62e9ad3b0a","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">In clinical\r trials, H275Y was the only resistance-associated treatment-emergent mutation in\r the neuraminidase gene that occurred in virus obtained from more than one\r peramivir-treated subject (in 9 of 481[1.9 %] infected with the A\/H1N1\r influenza virus). <\/span><\/p>","ID":"09e714d2-4319-4789-9b1a-5bcf173aa07c","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In clinical\r trials, H275Y was the only resistance-associated treatment-emergent mutation in\r the neuraminidase gene that occurred in virus obtained from more than one\r peramivir-treated subject (in 9 of 481[1.9 %] infected with the A\/H1N1\r influenza virus). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p>","ID":"f2cf1b3f-c0ab-4ffd-b04c-9d13ec6e113a","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Cross resistance<\/span><\/i><\/p>","ID":"051836ff-6a25-4f07-bd8b-8fa418287f92","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Cross resistance","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"BodytextAgency\" style=\"margin-bottom:0in;text-align:justify;text-justify:\r inter-ideograph;line-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;\r font-family:\"Times New Roman\",serif'>The H275Y substitution is associated with\r reduced susceptibility to peramivir and oseltamivir. Cross-resistance between\r peramivir and each of oseltamivir and zanamivir may also occur. <\/span><\/p>","ID":"044ee008-956c-47e2-ba85-1de207a23c15","Styles":"margin-bottom:0in;text-align:justify;text-justify:\r\ninter-ideograph;line-height:normal","Classes":"['BodytextAgency']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The H275Y substitution is associated with\r reduced susceptibility to peramivir and oseltamivir. Cross-resistance between\r peramivir and each of oseltamivir and zanamivir may also occur. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><s><span lang=\"EN-GB\" style=\"color:red\"><\/span><\/s><\/p>","ID":"916380e3-8913-4401-b99d-1861a602882b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-autospace:none\"><u><span lang=\"EN-GB\">Clinical\r studies<\/span><\/u><\/p>","ID":"ed86cd09-f707-4bc0-bf4b-20a80e36591e","Styles":"text-autospace:none","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Clinical\r studies","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><\/p>","ID":"d169a2a8-38b7-4883-806d-f37424b42af8","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><a name=\"_Hlk498508026\"><i><span lang=\"EN-GB\">Uncomplicated influenza in adults<\/span><\/i><\/a><\/p>","ID":"0bd5c2c2-2d7e-47dd-94f9-8c53f29b6e6b","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Uncomplicated influenza in adults","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">A randomised, multicentre, double-blind\r trial conducted in Japan evaluated a single intravenous administration of\r peramivir 300 mg or 600 mg, or placebo administered over\r 30 minutes in subjects 20 to 64 years of age withuncomplicated influenza. Subjects were eligible if\r they had fever greater than 38 <a name=\"_Hlk503778028\">\u00b0C<\/a> and a\r positive rapid antigen test for influenza virus, accompanied by at least two of\r the following symptoms: cough, nasal symptoms, sore throat, myalgia,\r chills\/sweats, malaise, fatigue or headache. <\/span><\/p>","ID":"022c435a-f5aa-42e9-a711-8071e5b92db3","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"A randomised, multicentre, double-blind\r trial conducted in Japan evaluated a single intravenous administration of\r peramivir 300 mg or 600 mg, or placebo administered over\r 30 minutes in subjects 20 to 64 years of age withuncomplicated influenza. Subjects were eligible if\r they had fever greater than 38 \u00b0C and a\r positive rapid antigen test for influenza virus, accompanied by at least two of\r the following symptoms: cough, nasal symptoms, sore throat, myalgia,\r chills\/sweats, malaise, fatigue or headache. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><\/p>","ID":"8b0a41cf-9b12-4e8e-beb6-0b0b3e68a97f","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">Study treatment was started within\r 48 hours of onset of symptoms. Subjects participating in the trial were\r required to self-assess their influenza symptoms as \u201cnone\u2019, \u2018mild\u2019, \u2018moderate\u2019\r or \u2018severe\u2019 twice daily. The primary endpoint, time to alleviation of symptoms,\r was defined as the number of hours from initiation of study drug until the\r start of the 24 hour period in which all seven symptoms of influenza\r (cough, sore throat, nasal congestion, headache, feverishness, myalgia and\r fatigue) were either absent or present at a level no greater than mild for at\r least 21.5 hours.<\/span><\/p>","ID":"0cbc92d1-7050-4b64-b8f0-01bf9d6b907a","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Study treatment was started within\r 48 hours of onset of symptoms. Subjects participating in the trial were\r required to self-assess their influenza symptoms as \u201cnone\u2019, \u2018mild\u2019, \u2018moderate\u2019\r or \u2018severe\u2019 twice daily. The primary endpoint, time to alleviation of symptoms,\r was defined as the number of hours from initiation of study drug until the\r start of the 24 hour period in which all seven symptoms of influenza\r (cough, sore throat, nasal congestion, headache, feverishness, myalgia and\r fatigue) were either absent or present at a level no greater than mild for at\r least 21.5 hours.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><\/p>","ID":"252e5620-489b-42b9-a17f-15ab3cbd74c6","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">The intent to treat influenza population\r (ITTI) included 296 subjects with influenza confirmed by polymerase chain\r reaction (PCR). Among the 97 subjects enrolled in the peramivir\r 600 mg dose group, 99 % were infected with influenza A virus (subtypes\r H1 and H3; 71 % and 26 %, respectively) and 1 % with influenza B\r virus. At enrollment 85 % of the 296 subjects had a composite influenza\r symptom score &lt;15. The mean temperature at enrolment was 38.6 \u00b0C\r (axillary). Key efficacy results are presented in Table 4.<\/span><\/p>","ID":"af5be4b8-22ae-4615-8d3c-6a3eb7dfc393","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The intent to treat influenza population\r (ITTI) included 296 subjects with influenza confirmed by polymerase chain\r reaction (PCR). Among the 97 subjects enrolled in the peramivir\r 600 mg dose group, 99 % were infected with influenza A virus (subtypes\r H1 and H3; 71 % and 26 %, respectively) and 1 % with influenza B\r virus. At enrollment 85 % of the 296 subjects had a composite influenza\r symptom score <15. The mean temperature at enrolment was 38.6 \u00b0C\r (axillary). Key efficacy results are presented in Table 4.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><\/p>","ID":"a42b81e7-c57f-45ea-b355-c5c4a083dc51","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><b><span lang=\"EN-GB\">Table 4: Key\r efficacy results from study 0722T0621 (ITTI Population)<\/span><\/b><\/p>","ID":"0703677e-3fd6-4876-93fd-50f25ddd7c3f","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Table 4: Key\r efficacy results from study 0722T0621 (ITTI Population)","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:418.1pt;border-collapse:collapse\" width=\"557\"> <tr> <td style=\"width:45.68%;border:inset 1.0pt;border-bottom:\r   solid windowtext 1.0pt;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"><\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span style=\"color:black\">Peramivir 600 mg<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">n=97<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span style=\"color:black\">Placebo<\/span><\/b><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">n=100<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:45.68%;border:inset 1.0pt;border-top:\r   none;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"> <p class=\"MsoNormal\" style=\"line-height:normal\">Time to alleviation of symptoms<\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">median\r   (hours)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">(95 %\r   CI)<\/span><\/p> <\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">59.9<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(54.4, 68.1)<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">81.8<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(68.0, 101.5)<\/span><\/p> <\/td> <\/tr> <tr> <td style=\"width:45.68%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"top\" width=\"45%\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">Time\r   to recovery of normal temperature median (hours)<\/span><\/p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">(95 %\r   CI)<\/span><\/p> <\/td> <td style=\"width:27.14%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">30.2<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(25.9, 31.9)<\/span><\/p> <\/td> <td style=\"width:27.2%;padding:1.2pt 1.2pt 1.2pt 1.2pt\" valign=\"bottom\" width=\"27%\"> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">42.4<\/span><\/p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span style=\"color:black\">(32.9, 46.5)<\/span><\/p> <\/td> <\/tr> <\/table>","ID":"37dc5ca9-ad46-4b59-8f3d-cb2d8edc5c78","Styles":"width:418.1pt;border-collapse:collapse","Classes":"['MsoNormalTable']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"    Peramivir 600 mg n=97   Placebo n=100     Time to alleviation of symptoms median\r   (hours) (95 %\r   CI)   59.9 (54.4, 68.1)   81.8 (68.0, 101.5)     Time\r   to recovery of normal temperature median (hours) (95 %\r   CI)   30.2 (25.9, 31.9)   42.4 (32.9, 46.5)   ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><span lang=\"EN-GB\">CI = Confidence\r Interval <\/span><\/p>","ID":"400ca30a-e2e7-4135-a235-1152afbccca9","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"CI = Confidence\r Interval ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"9864a190-8cfb-4f05-9aa3-6795132c0936","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Uncomplicated\r influenza in paediatric subjects aged 2-17 years<\/span><\/i><\/p>","ID":"22d5f56f-42bf-4938-bf59-8cd5713ee5d9","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Uncomplicated\r influenza in paediatric subjects aged 2-17 years","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety of peramivir\r was evaluated in a randomised, active-controlled study of 110 subjects\r with uncomplicated influenza who received open label treatment with a single\r dose of peramivir (600 mg for subjects 13 to 17 years of age and 12 mg\/kg\r up to a maximum dose of 600 mg in subjects 2 to 12 years of age) or oral\r oseltamivir administered twice daily for 5 days. <\/span><span lang=\"EN-GB\">The\r ITTI population included 84 subjects with influenza confirmed by PCR. Among the\r 93 subjects enrolled in the peramivir dose group, 43% were infected with\r influenza A virus (subtypes H1 and H3; 54 % and 46 %, respectively) and 27%\r with influenza B virus. <\/span><span lang=\"EN-GB\">Randomisation was 4:1 for peramivir\r and oseltamivir. Treatment was given or commenced within 48 hours of onset\r of symptoms of influenza. Efficacy (time to resolution of fever; time to\r resolution of influenza symptoms, viral shedding, virus susceptibility) was a\r secondary endpoint.<\/span><\/p>","ID":"6450f1b9-3a32-4a86-b8b4-893f31e550fc","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The safety of peramivir\r was evaluated in a randomised, active-controlled study of 110 subjects\r with uncomplicated influenza who received open label treatment with a single\r dose of peramivir (600 mg for subjects 13 to 17 years of age and 12 mg\/kg\r up to a maximum dose of 600 mg in subjects 2 to 12 years of age) or oral\r oseltamivir administered twice daily for 5 days. The\r ITTI population included 84 subjects with influenza confirmed by PCR. Among the\r 93 subjects enrolled in the peramivir dose group, 43% were infected with\r influenza A virus (subtypes H1 and H3; 54 % and 46 %, respectively) and 27%\r with influenza B virus. Randomisation was 4:1 for peramivir\r and oseltamivir. Treatment was given or commenced within 48 hours of onset\r of symptoms of influenza. Efficacy (time to resolution of fever; time to\r resolution of influenza symptoms, viral shedding, virus susceptibility) was a\r secondary endpoint.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e0337701-b870-4533-91b9-945094b39534","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Subjects\r receiving peramivir experienced a median time to alleviation of their combined\r influenza symptoms of 79.0 hours and the median time to recovery to normal\r temperature (less than 37 \u00b0C) was approximately 40.0 hours.<\/span><\/p>","ID":"6e60a354-3548-4f2b-9d91-3cb1d00ea963","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Subjects\r receiving peramivir experienced a median time to alleviation of their combined\r influenza symptoms of 79.0 hours and the median time to recovery to normal\r temperature (less than 37 \u00b0C) was approximately 40.0 hours.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"0e1c22be-9f07-4477-a628-87a21330ab1c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly\r patients<\/span><\/i><\/p>","ID":"524f7ea0-9297-4534-ab0c-dcb8625ec1ba","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Elderly\r patients","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Clinical trials\r in which single intravenous doses of peramivir were administered to patients\r with uncomplicated influenza included few subjects aged 65 and over (n=10).<\/span><\/p>","ID":"bb70d2f6-367e-415e-bdea-7af46603ee8b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Clinical trials\r in which single intravenous doses of peramivir were administered to patients\r with uncomplicated influenza included few subjects aged 65 and over (n=10).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"794517c1-9a71-48dd-ae17-c3b125e59d33","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred\r the obligation to submit the results of studies with Alpivab in one or more\r subsets of the paediatric population for the treatment of influenza (see\r section 4.2 for information on paediatric use).<\/span><\/p>","ID":"d8beeae7-cfc5-4f34-97d4-9d6c95df7533","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The European Medicines Agency has deferred\r the obligation to submit the results of studies with Alpivab in one or more\r subsets of the paediatric population for the treatment of influenza (see\r section 4.2 for information on paediatric use).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"67511def-05c6-497e-b242-ba6dee663fa7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties<\/span><\/b><\/p>","ID":"2527dca8-24f0-416f-94d5-2cbfb3a2a479","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"5.2     Pharmacokinetic properties","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2b45725f-516e-40ce-b905-e9f2b25b01a1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Absorption<\/span><\/u><\/p>","ID":"ee9d4525-6e7e-4591-93d3-a48a62d2ba33","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Absorption","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"ab2539cf-50d4-44e9-b631-d1a6834ddea8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetic parameters following intravenous (IV) administration of peramivir\r (0.17 to 2 times the recommended dose) showed a linear relationship\r between dose and exposure parameters (maximum serum concentration [C<sub>max<\/sub>]\r and area under the curve [AUC]). Following intravenous administration of a\r single dose of peramivir 600 mg over 30 minutes, C<sub>max<\/sub> was\r reached at the end of infusion. <\/span><\/p>","ID":"8cc48428-6dac-4254-96c1-9984bcbc2307","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The\r pharmacokinetic parameters following intravenous (IV) administration of peramivir\r (0.17 to 2 times the recommended dose) showed a linear relationship\r between dose and exposure parameters (maximum serum concentration [Cmax]\r and area under the curve [AUC]). Following intravenous administration of a\r single dose of peramivir 600 mg over 30 minutes, Cmax was\r reached at the end of infusion. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"c1ba66e8-d9ff-4a5c-801e-1cd608c42bf3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Distribution<\/span><\/u><\/p>","ID":"03577326-b8cf-41bc-a05c-321aced0a04a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Distribution","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"1775ae1c-6c27-4004-9b04-c34c0f5a7143","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In-vitro<\/span><\/i><span lang=\"EN-GB\"> binding of peramivir to human plasma proteins is less than 30 %.\r <\/span><\/p>","ID":"9425281e-20ac-446c-9ef3-481dd7ea2b38","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In-vitro binding of peramivir to human plasma proteins is less than 30 %.\r ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on a\r population pharmacokinetic analysis, the central volume of distribution was\r 12.56 L.<\/span><\/p>","ID":"7cd05f24-a0a5-45ab-8e38-24feea625911","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Based on a\r population pharmacokinetic analysis, the central volume of distribution was\r 12.56 L.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"cb5840be-b8b6-4b8a-8904-3a2eab831c81","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Biotransformation<\/span><\/u><\/p>","ID":"49d27093-2b8b-4fae-93a3-102264dd850b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Biotransformation","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"278c96cd-7294-4413-b230-9e0edc517975","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir is not\r significantly metabolised in humans.<\/span><\/p>","ID":"8cea41f7-dcca-4736-8851-ef201d7711c4","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir is not\r significantly metabolised in humans.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"62163252-dc2d-4318-9e68-27bce73733f7","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination<\/span><\/u><\/p>","ID":"812520a9-7719-471b-9c65-f748ce6d08ca","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Elimination","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"4ce0036c-85a5-4d93-9bc3-41d78d345bca","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The elimination half-life of peramivir following IV administration\r to healthy subjects of 600 mg as a single dose is approximately 20 hours.\r The major route of elimination of peramivir is via the kidney. Renal clearance\r of unchanged peramivir accounts for approximately 90 % of total clearance.<\/span><\/p>","ID":"376684a1-5406-4726-b916-ecc1537c677c","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The elimination half-life of peramivir following IV administration\r to healthy subjects of 600 mg as a single dose is approximately 20 hours.\r The major route of elimination of peramivir is via the kidney. Renal clearance\r of unchanged peramivir accounts for approximately 90 % of total clearance.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"7b0ce66f-35e9-4b85-b31f-0da5a47d45bd","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations<\/span><\/u><\/p>","ID":"42acbba4-195a-434b-a7f6-e9f2eae064f2","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Special populations","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"e983c9c4-5ff9-49fc-948d-d2e94731a6f3","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Race<\/span><\/i><\/p>","ID":"c81245ad-1402-45ad-8b83-22d047a53a47","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Race","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><a name=\"_Hlk498601677\"><span lang=\"EN-GB\">In simulations of a\r single dose of 600 mg, the predicted AUC in Asians (AUC<sub>0-24<\/sub> 88,800\r ng<\/span><\/a><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">h\/mL) was slightly\r higher as compared to Non-Asians (AUC<sub>0-24<\/sub> 77,200 ng<\/span><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">h\/mL).  <\/span><\/p>","ID":"10483099-00c4-40c9-ae50-d5823e3e9f09","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In simulations of a\r single dose of 600 mg, the predicted AUC in Asians (AUC0-24 88,800\r ng\u2022h\/mL) was slightly\r higher as compared to Non-Asians (AUC0-24 77,200 ng\u2022h\/mL).  ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"456f78d7-5d61-4339-8fc2-2d2a30c4bb0a","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Gender<\/span><\/i><\/p>","ID":"0afd9341-a8ee-49df-8520-b9e3e32aebf8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Gender","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetics of peramivir following a 600 mg intramuscular (IM) injection was\r similar in males and females with AUC<sub>0-\u221e<\/sub> of 76,600 ng\u2022hr\/mL\r and 101,000 ng\u2022hr\/mL, respectively, and C<sub>max<\/sub> of 27,760 ng\/mL\r and 34,710 ng\/mL, respectively.<\/span><\/p>","ID":"6daa23b2-6134-4235-8d6a-f7d6ce544d15","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The\r pharmacokinetics of peramivir following a 600 mg intramuscular (IM) injection was\r similar in males and females with AUC0-\u221e of 76,600 ng\u2022hr\/mL\r and 101,000 ng\u2022hr\/mL, respectively, and Cmax of 27,760 ng\/mL\r and 34,710 ng\/mL, respectively.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"c26bb8ee-c718-4bb2-81e8-239e6f84f2ad","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk503609111\"><i><span lang=\"EN-GB\">Paediatrics<\/span><\/i><\/a><\/p>","ID":"22597cd7-445e-409e-a1f9-f88d1efce772","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Paediatrics","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Hlk497130888\"><span lang=\"EN-GB\">The pharmacokinetics of peramivir has been evaluated in a study in\r paediatric subjects 2 to 17 years of age with uncomplicated influenza.\r Pharmacokinetic sampling in this study was limited to approximately 3 hours\r after administration of peramivir. Pharmacokinetics of peramivir in subjects 2\r to 17 years of age (administered 12 mg\/kg or 600 mg according to age and\r body weight) and in healthy adults (administered 600 mg) was similar\r (Table 5). <\/span><\/a><\/p>","ID":"38e2de89-a2e5-450f-ae9c-14bfedfb134f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The pharmacokinetics of peramivir has been evaluated in a study in\r paediatric subjects 2 to 17 years of age with uncomplicated influenza.\r Pharmacokinetic sampling in this study was limited to approximately 3 hours\r after administration of peramivir. Pharmacokinetics of peramivir in subjects 2\r to 17 years of age (administered 12 mg\/kg or 600 mg according to age and\r body weight) and in healthy adults (administered 600 mg) was similar\r (Table 5). ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"86fdf62f-41af-4cef-bc0a-18987f1dc16e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt\"><b><span lang=\"EN-GB\">Table 5: Pharmacokinetic\r parameters in paediatric subjects <\/span><\/b><\/p>","ID":"1d8036d4-76ce-42f1-bb34-4cccbdf162eb","Styles":"margin-right:-.1pt","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Table 5: Pharmacokinetic\r parameters in paediatric subjects ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\"> <tr style=\"height:28.3pt\"> <td style=\"width:103.25pt;border:solid windowtext 1.0pt;padding:\r   0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">Age Group<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><\/p> <\/td> <td style=\"width:.5in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">N<\/span><\/b><\/p> <\/td> <td style=\"width:1.25in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">C<sub>max<\/sub> (ng\/mL)<\/span><\/b><\/p> <\/td> <td style=\"width:1.5in;border:solid windowtext 1.0pt;border-left:\r   none;padding:0in 5.4pt 0in 5.4pt;height:28.3pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:11.0pt\">AUC<sub>last<\/sub> (ng<\/span><\/b>\u2022<b><span style=\"font-size:11.0pt\">h\/mL)<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"height:17.5pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">2 years - &lt;7 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">28<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">53,600 (26,200)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">74,000 (30,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:19.3pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:19.3pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:19.3pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:19.3pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">47,400<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:19.3pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">68,100<\/span><\/p> <\/td> <\/tr> <tr style=\"height:14.35pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:14.35pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:14.35pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:14.35pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">48.9<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:14.35pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">40.6<\/span><\/p> <\/td> <\/tr> <tr style=\"height:16.15pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">7 years - &lt;13 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:16.15pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">39<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:16.15pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">66,800 (35,400)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:16.15pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">87,000 (40,800)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:18.4pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:18.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:18.4pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:18.4pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">61200<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:18.4pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">81,000<\/span><\/p> <\/td> <\/tr> <tr style=\"height:15.25pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.25pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.25pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:15.25pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">53.0<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:15.25pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">46.8<\/span><\/p> <\/td> <\/tr> <tr style=\"height:27.4pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">13 years - &lt;18<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:27.4pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">20<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:27.4pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">54,300 (17,900)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:27.4pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">72,400 (20,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.5pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.5pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">51,500<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.5pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">69,500<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">33.0<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">27.6<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td rowspan=\"3\" style=\"width:103.25pt;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><b><span style=\"font-size:11.0pt\">2 years - &lt;18 years<\/span><\/b><\/p> <\/td> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Mean (SD)<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">87<\/span><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">59,700 (29,700)<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">79,500 (34,000)<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">Geometric Mean<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">54,200<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">74,000<\/span><\/p> <\/td> <\/tr> <tr style=\"height:17.05pt\"> <td style=\"width:103.5pt;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"138\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">%CV<\/span><\/p> <\/td> <td style=\"width:.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"48\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><\/p> <\/td> <td style=\"width:1.25in;border-top:none;border-left:none;\r   border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" width=\"120\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">49.8<\/span><\/p> <\/td> <td style=\"width:1.5in;border-top:none;border-left:none;border-bottom:\r   solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;\r   height:17.05pt\" width=\"144\"> <p align=\"center\" class=\"C-BodyText\" style=\"margin:0in;text-align:center;\r   line-height:normal\"><span style=\"font-size:11.0pt\">42.7<\/span><\/p> <\/td> <\/tr> <\/table>","ID":"23d984d5-3d7f-43cf-8a4e-39c6fbaeb9e6","Styles":"border-collapse:collapse;border:none","Classes":"['MsoNormalTable']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"   Age Group      N   Cmax (ng\/mL)   AUClast (ng\u2022h\/mL)     2 years - <7 years   Mean (SD)   28   53,600 (26,200)   74,000 (30,000)     Geometric Mean      47,400   68,100     %CV      48.9   40.6     7 years - <13 years   Mean (SD)   39   66,800 (35,400)   87,000 (40,800)     Geometric Mean      61200   81,000     %CV      53.0   46.8     13 years - <18   Mean (SD)   20   54,300 (17,900)   72,400 (20,000)     Geometric Mean      51,500   69,500     %CV      33.0   27.6     2 years - <18 years   Mean (SD)   87   59,700 (29,700)   79,500 (34,000)     Geometric Mean      54,200   74,000     %CV      49.8   42.7   ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SD = Standard\r Deviation; CV = Coefficient of Variation<\/span><\/p>","ID":"f5551b39-3d45-46f7-baa8-1ac9422d02f3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"SD = Standard\r Deviation; CV = Coefficient of Variation","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\" style=\"color:red\"><\/span><\/u><\/p>","ID":"56407f30-e7ad-4421-8d40-22c629537d29","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Elderly<\/span><\/i><\/p>","ID":"b1629b6d-5848-4f72-a0bc-9821570bf20a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Elderly","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The pharmacokinetics\r of peramivir was evaluated in 20 elderly subjects (&gt;65 years of age)\r following a single 4 mg\/kg IV dose of peramivir. The elderly subjects\r enrolled were aged 65 to 79 years, with a mean age of 70.1 years, with creatinine\r clearance (Cockcroft-Gault calculation) CrCl<sub>cg<\/sub> ranging from 82.8\r mL\/min to 197.9 mL\/min. The <\/span><span lang=\"EN-GB\">pharmacokinetics in elderly\r subjects was similar to non-elderly subjects.<\/span><span lang=\"EN-GB\"> Mean peak\r concentrations of peramivir were approximately 10 % higher in elderly\r subjects following administration of a single dose when compared to young\r adults (22,647 vs. 20,490 ng\/mL, respectively). Exposure (AUC<sub>0-12<\/sub>)\r to peramivir following a single dose was approximately 33 % higher in\r elderly subjects compared to young adults (61,334 vs. 46,200 ng<\/span><span lang=\"EN-GB\">\u2022<\/span><span lang=\"EN-GB\">hr\/mL, respectively).<\/span><\/p>","ID":"6ddbb1d0-3332-48ce-acbc-6c5c4b670a66","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The pharmacokinetics\r of peramivir was evaluated in 20 elderly subjects (>65 years of age)\r following a single 4 mg\/kg IV dose of peramivir. The elderly subjects\r enrolled were aged 65 to 79 years, with a mean age of 70.1 years, with creatinine\r clearance (Cockcroft-Gault calculation) CrClcg ranging from 82.8\r mL\/min to 197.9 mL\/min. The pharmacokinetics in elderly\r subjects was similar to non-elderly subjects. Mean peak\r concentrations of peramivir were approximately 10 % higher in elderly\r subjects following administration of a single dose when compared to young\r adults (22,647 vs. 20,490 ng\/mL, respectively). Exposure (AUC0-12)\r to peramivir following a single dose was approximately 33 % higher in\r elderly subjects compared to young adults (61,334 vs. 46,200 ng\u2022hr\/mL, respectively).","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e08c198b-c5a6-4b35-9f61-a46dff3632bb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Renal impairment<\/span><\/i><\/p>","ID":"3987d859-0f58-45e0-913c-7c91a985cee9","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Renal impairment","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a study in\r subjects with various degrees of renal impairment and subjects with normal\r renal function, a single 2 mg\/kg IV dose of peramivir was administered.\r Serum creatinine measurements were used to calculate creatinine clearance\r (Cockcroft-Gault equation). The mean AUC<sub>0-<\/sub><\/span><sub><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b5<\/span><\/sub><span lang=\"EN-GB\"> was\r increased by 28 %, 302 % and 412 % in subjects with creatinine clearance of 50\u201179,\r 30\u201149 and 10\u201129 mL\/min, respectively. Haemodialysis initiated at 2 hours\r after dosing reduced systemic exposure of peramivir by 73 to 81 %.<\/span><\/p>","ID":"0e56cd64-8784-4585-8df8-9061e04b7229","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"In a study in\r subjects with various degrees of renal impairment and subjects with normal\r renal function, a single 2 mg\/kg IV dose of peramivir was administered.\r Serum creatinine measurements were used to calculate creatinine clearance\r (Cockcroft-Gault equation). The mean AUC0-\u00b5 was\r increased by 28 %, 302 % and 412 % in subjects with creatinine clearance of 50\u201179,\r 30\u201149 and 10\u201129 mL\/min, respectively. Haemodialysis initiated at 2 hours\r after dosing reduced systemic exposure of peramivir by 73 to 81 %.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"0cd51e9d-ccef-412f-9f5e-9d8b88db3a12","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">Hepatic impairment<\/span><\/i><\/p>","ID":"c11b79f3-bcee-4f03-8370-e48818196c5a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":true,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L4","Text":"Hepatic impairment","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The\r pharmacokinetics of peramivir in subjects with hepatic impairment has not been\r studied. No clinically relevant alterations to peramivir pharmacokinetics are\r expected in patients with hepatic impairment based on the route of peramivir\r elimination.<\/span><\/p>","ID":"3d805743-bfd7-49a7-991f-c1bf2822a7f8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The\r pharmacokinetics of peramivir in subjects with hepatic impairment has not been\r studied. No clinically relevant alterations to peramivir pharmacokinetics are\r expected in patients with hepatic impairment based on the route of peramivir\r elimination.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p>","ID":"b3d75ba7-b5f9-4535-b839-7e73d7acb591","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety\r data<\/span><\/b><\/p>","ID":"f7618202-5e75-45a5-8ebc-a9aab7903eb0","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"5.3     Preclinical safety\r data","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"98b219dc-abf7-4bae-afe9-6866acf7cecd","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\r avoid\"><span lang=\"EN-GB\">Peramivir was not teratogenic in embryo-fetal\r development studies in rats and rabbits and had no effects on mating or\r fertility in rats up to 600 mg\/kg\/day, at which exposures were\r approximately 8\u2011fold of those in humans at the clinically recommended\r dose. However, in an embryo-foetal development study in rats, in which dams\r received continuous infusions of peramivir from day 6\u201117 of gestation at\r does of 50, 400 or 1000 mg\/kg\/day, dose related increases in the\r incidences of reduction of the renal papillae and dilatation of the ureters\r were observed. The teratological importance of these findings is unclear.<\/span><\/p>","ID":"bb79b8bc-9d81-4b3c-b4e2-d9e28dbf1d3d","Styles":"margin-right:-.1pt;line-height:normal;page-break-after:\r\navoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir was not teratogenic in embryo-fetal\r development studies in rats and rabbits and had no effects on mating or\r fertility in rats up to 600 mg\/kg\/day, at which exposures were\r approximately 8\u2011fold of those in humans at the clinically recommended\r dose. However, in an embryo-foetal development study in rats, in which dams\r received continuous infusions of peramivir from day 6\u201117 of gestation at\r does of 50, 400 or 1000 mg\/kg\/day, dose related increases in the\r incidences of reduction of the renal papillae and dilatation of the ureters\r were observed. The teratological importance of these findings is unclear.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><\/p>","ID":"262e9c15-8f5e-4c87-9957-434d17d095ae","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Carcinogenicity studies by intravenous injection of peramivir were\r not performed. <\/span><\/p>","ID":"a0fec705-7fa0-48f3-a3e2-68bffa32d9f3","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Carcinogenicity studies by intravenous injection of peramivir were\r not performed. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"5992d4f6-bb2f-46ad-afa4-866a2390b6fe","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peramivir was\r not mutagenic or clastogenic in a battery of <i>in-vitro<\/i> and <i>in-vivo<\/i>\r assays.<\/span><\/p>","ID":"7aa7d8a6-5608-4e34-9a81-6caeb633f104","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Peramivir was\r not mutagenic or clastogenic in a battery of in-vitro and in-vivo\r assays.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"6a60363d-5a1b-4aa8-9940-3f9c6a0318d6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Acute renal\r necrosis was found in rabbits at doses \u2265 200 mg\/kg with a clear no\r observed adverse effect level (NOAEL) established in multiple studies at 100 mg\/kg\/day.\r <\/span><\/p>","ID":"1d770d13-29f9-4e9e-bf4a-51d42266c3b2","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Acute renal\r necrosis was found in rabbits at doses \u2265 200 mg\/kg with a clear no\r observed adverse effect level (NOAEL) established in multiple studies at 100 mg\/kg\/day.\r ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"cd34a9c9-3aff-43c7-bd4f-f8eec1653a63","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Two-week oral\r toxicity studies were conducted in juvenile rats and rabbits, and a four-week\r IV toxicity study was conducted in juvenile rats. In general, nephrotoxicity\r was observed in rabbits, no unexpected toxicity was observed, and no other\r target organ toxicity was identified in juvenile animals.<\/span><\/p>","ID":"f599733e-5b5e-4cc3-a9af-f1a861c84e25","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Two-week oral\r toxicity studies were conducted in juvenile rats and rabbits, and a four-week\r IV toxicity study was conducted in juvenile rats. In general, nephrotoxicity\r was observed in rabbits, no unexpected toxicity was observed, and no other\r target organ toxicity was identified in juvenile animals.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"c5e32c78-784f-4a04-8d44-747b923ddac0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d2930591-1fc4-4a3b-a12f-8120f0da9cd8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS<\/span><\/b><\/p>","ID":"539f5100-b01e-4adb-bd3a-39804bdb389a","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"6.       PHARMACEUTICAL PARTICULARS","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"27af5a03-5abd-4a85-b505-99806e259c62","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.1     List of excipients<\/span><\/b><\/p>","ID":"271061e6-a17e-4bbb-87b7-12ecb4873305","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.1     List of excipients","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b0078136-2f1d-4abe-a91a-8769563f081b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride<\/span><\/p>","ID":"2b9312c9-9c4d-4fc3-9dca-71fc602e542b","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Sodium chloride","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections<\/span><\/p>","ID":"2141485d-94a1-4608-a44f-cf934fad9f84","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Water for injections","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium hydroxide\r (for pH adjustment)<\/span><\/p>","ID":"aa705bb4-563f-4086-88fa-1d817fe45c64","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Sodium hydroxide\r (for pH adjustment)","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal\"><span lang=\"EN-GB\">Hydrochloric acid (for pH adjustment)<\/span><\/p>","ID":"ded77c64-d711-4246-b70b-4959f612d86c","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Hydrochloric acid (for pH adjustment)","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f52b562a-cb0f-407f-8acf-c6a5ed0bf021","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.2     Incompatibilities<\/span><\/b><\/p>","ID":"d753e019-e2df-4aa5-8e33-83708600e756","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.2     Incompatibilities","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"8e77466c-8a04-4783-bad3-dd54ae977d72","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\r product must not be mixed with other medicinal products except those mentioned\r in section 6.6.<\/span><\/p>","ID":"a18d66f1-d19d-4233-8b95-23fcc29fdb72","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"This medicinal\r product must not be mixed with other medicinal products except those mentioned\r in section 6.6.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"30bc2eab-6f40-4108-b6db-785e5f2b52f3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.3     Shelf life<\/span><\/b><\/p>","ID":"0373ab99-3aa0-4a4a-a369-43eb202a42be","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.3     Shelf life","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"4ed01e62-ae2a-4664-b44d-c334bd3e2f85","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Unopened vial<\/span><\/u><\/p>","ID":"ff99206a-bc2d-4b5b-b735-f89485a1c4f3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"Unopened vial","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"40271f37-9d4d-4515-a1e3-585965d1b511","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5 years<\/span><\/p>","ID":"42a3e3c6-440f-4d7f-8007-4e860b14cae0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"5 years","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"1c8c1e24-cbad-422c-987f-35e41e162b4f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">After\r dilution<\/span><\/u><\/p>","ID":"7f7e34ef-769f-4239-b05b-c8be09af759e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":true,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L3","Text":"After\r dilution","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><\/span><\/u><\/p>","ID":"85d01de1-5132-41b8-88c6-195b310c3431","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">Chemical and physical in-use stability has\r been demonstrated for 72 hours at 5 \u00baC and 25 \u00baC.<\/span><\/p>","ID":"39499aa9-8912-4652-9b99-d97a61c13533","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Chemical and physical in-use stability has\r been demonstrated for 72 hours at 5 \u00baC and 25 \u00baC.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><span lang=\"EN-GB\">From a microbiological point of view, the\r product, once diluted, should be used immediately.<\/span><span lang=\"EN-GB\">If not used immediately in-use storage times and conditions prior to\r use are the responsibility of the user and would normally not be longer than 24\r hours at 2 \u00baC to 8 \u00baC, unless dilution has taken place in controlled and\r validated aseptic conditions.<\/span><\/p>","ID":"4542c5d9-4193-42fe-90a2-a49b0034f8c3","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"From a microbiological point of view, the\r product, once diluted, should be used immediately.If not used immediately in-use storage times and conditions prior to\r use are the responsibility of the user and would normally not be longer than 24\r hours at 2 \u00baC to 8 \u00baC, unless dilution has taken place in controlled and\r validated aseptic conditions.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f722817a-0d63-401d-ba7f-8d3a7d33c091","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage<\/span><\/b><\/p>","ID":"864ea2f5-d049-47f6-ac76-5ef3bc6318d6","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.4     Special precautions for storage","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"8c424952-21a2-4079-8df6-6b2ed26a8fe8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not refrigerate\r or freeze.<\/span><\/p>","ID":"aeaa37be-4500-4627-9f6a-7e6008b7db67","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Do not refrigerate\r or freeze.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage\r conditions after dilution of the medicinal product, see section 6.3.<\/span><\/p>","ID":"094a3fa2-db53-4cb3-bc50-7a8b3adb1011","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"For storage\r conditions after dilution of the medicinal product, see section 6.3.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2dffb749-5849-446f-b9e9-9933739c9f49","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container<\/span><\/b><\/p>","ID":"b4825126-825c-4f95-a8d7-11b6ee8a411a","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.5     Nature and contents of container","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\r line-height:normal;page-break-after:avoid\"><\/p>","ID":"ad9e1750-2b33-4a7a-868d-09aa50e23190","Styles":"text-align:justify;text-justify:inter-ideograph;\r\nline-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Clear glass vial (Type I) with a coated bromobutyl-rubber stopper, aluminium\r overseal and flip-off cap. <\/span><\/p>","ID":"b5db86f2-410e-41ab-b138-299283c33a24","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Clear glass vial (Type I) with a coated bromobutyl-rubber stopper, aluminium\r overseal and flip-off cap. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"90f85975-01fb-44f2-b9b4-9820e868fc05","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack size of 3\r single-use vials.<\/span><\/p>","ID":"120d381f-07e6-4a86-8f78-ebe6a2e999eb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Pack size of 3\r single-use vials.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"44bbbd25-f261-4843-a9b8-9cd33255f3d9","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special\r precautions for disposal and other handling<\/span><\/b><\/a><\/p>","ID":"a27c3e27-b912-4211-a727-e0b85383414f","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L2","Text":"6.6     Special\r precautions for disposal and other handling","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","ID":"a0c71536-6a2a-4dc1-8782-e749f28fb9e2","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Aseptic technique should be used during the preparation of Alpivab\r to prevent inadvertent microbial contamination. <\/span><\/p>","ID":"82fc53c5-365a-47cf-a692-aca3127aa822","Styles":"line-height:normal;page-break-after:avoid","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Aseptic technique should be used during the preparation of Alpivab\r to prevent inadvertent microbial contamination. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"26efd8b2-e821-4945-b78c-7fdc72640d1f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The following\r steps should be followed to prepare a diluted solution of peramivir:<\/span><\/p>","ID":"aa4ec63c-0caa-4960-9ebb-6c8dd128e9b3","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"The following\r steps should be followed to prepare a diluted solution of peramivir:","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\r line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Check\r the seal of each vial. Do not use if seal opening is broken or missing.<\/span><\/p>","ID":"4a1cd156-2df5-4dc1-a8d0-e14ee5bba24e","Styles":"margin-left:28.35pt;text-indent:-28.35pt;\r\nline-height:normal","Classes":"['MsoListParagraphCxSpFirst']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Check\r the seal of each vial. Do not use if seal opening is broken or missing.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Visually\r inspect the peramivir concentrate 10 mg\/mL. It must be colourless and\r without particulate matter. <\/span><\/p>","ID":"4cfb43f6-be34-47f1-95c9-2b0b357942c7","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Visually\r inspect the peramivir concentrate 10 mg\/mL. It must be colourless and\r without particulate matter. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a\r patient receives 600 mg peramivir the required volume of peramivir\r concentrate is 60 mL (3 vials with 20 mL each). In the case of a\r 300 mg peramivir dose, 30 mL (1\u00bd vials) of peramivir concentrate\r is needed and for a 200 mg dose, only 20 mL (1 vial). Fractions\r of a vial may be needed for appropriate dose adjustments in children with a\r bodyweight of less than 50 kg.<\/span><\/p>","ID":"2408a7a9-10f3-4a21-b211-5e5490369a43","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal;page-break-after:avoid","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7If a\r patient receives 600 mg peramivir the required volume of peramivir\r concentrate is 60 mL (3 vials with 20 mL each). In the case of a\r 300 mg peramivir dose, 30 mL (1\u00bd vials) of peramivir concentrate\r is needed and for a 200 mg dose, only 20 mL (1 vial). Fractions\r of a vial may be needed for appropriate dose adjustments in children with a\r bodyweight of less than 50 kg.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Add\r the measured volume of peramivir concentrate into the infusion container.<\/span><\/p>","ID":"5f4b8533-0653-400d-80b7-1aed05c595cf","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Add\r the measured volume of peramivir concentrate into the infusion container.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dilute\r the required dose of peramivir concentrate in sodium chloride 9 mg\/mL (0.9 %)\r or 4.5 mg\/mL (0.45 %) solution for infusion, 5 % dextrose or\r Ringer lactate solution to a volume of 100 mL.<\/span><\/p>","ID":"1b49c90a-2c34-443b-94fc-76862c9a7997","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Dilute\r the required dose of peramivir concentrate in sodium chloride 9 mg\/mL (0.9 %)\r or 4.5 mg\/mL (0.45 %) solution for infusion, 5 % dextrose or\r Ringer lactate solution to a volume of 100 mL.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Administer\r the diluted solution via intravenous infusion for 15 to 30 minutes.<\/span><\/p>","ID":"c233a527-89ce-449b-8fc1-c9b81cc3ade7","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Administer\r the diluted solution via intravenous infusion for 15 to 30 minutes.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpMiddle\" style=\"margin-left:28.35pt;text-indent:\r -28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Once\r a diluted peramivir solution has been prepared, administer immediately or store\r in a refrigerator (2 \u00b0C to 8 \u00b0C) for up to 24 hours. If\r refrigerated, allow the diluted peramivir solution to reach room temperature,\r then administer immediately.<\/span><\/p>","ID":"dc3a564b-2d82-4124-ac71-f8794f4534b5","Styles":"margin-left:28.35pt;text-indent:\r\n-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpMiddle']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Once\r a diluted peramivir solution has been prepared, administer immediately or store\r in a refrigerator (2 \u00b0C to 8 \u00b0C) for up to 24 hours. If\r refrigerated, allow the diluted peramivir solution to reach room temperature,\r then administer immediately.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoListParagraphCxSpLast\" style=\"margin-top:0in;margin-right:0in;\r margin-bottom:0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Discard\r any unused diluted solution of peramivir after 24 hours.<\/span><\/p>","ID":"48f28290-cb43-45f0-b7a4-d3a6584fb7a0","Styles":"margin-top:0in;margin-right:0in;\r\nmargin-bottom:0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal","Classes":"['MsoListParagraphCxSpLast']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":true,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"\u00b7Discard\r any unused diluted solution of peramivir after 24 hours.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e3392d8a-6a69-4ba5-a9e3-413230b6a3cb","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\r medicinal product or waste material should be disposed of in accordance with\r local requirements.<\/span><\/p>","ID":"41a228b9-a473-4bd1-8cc9-4ce0f2f70356","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Any unused\r medicinal product or waste material should be disposed of in accordance with\r local requirements.","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\"><\/p>","ID":"e766ece8-7cd9-4f4d-b004-8173de4dd05e","Styles":"None","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"911aefc2-a221-40a2-977f-8a1139fc70cf","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER<\/span><\/b><\/p>","ID":"504bf04a-fc71-4fbb-9d12-1a9016b029a0","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"7.       MARKETING AUTHORISATION HOLDER","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"3485ef40-a10f-4927-915b-74732ebdaf82","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">BioCryst UK Ltd,\r <\/span><\/p>","ID":"32d4b9e4-d030-4c63-aa52-0845913ad80e","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"BioCryst UK Ltd,\r ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">c\/o Morgan Lewis\r &amp; Bockius<\/span><\/p>","ID":"ce385c99-7dcb-4152-b877-069d4e805a82","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"c\/o Morgan Lewis\r & Bockius","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Condor House, <\/span><\/p>","ID":"f620ceb5-335e-4931-91fb-9b190a202216","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Condor House, ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5-10 St. Paul's\r Churchyard, <\/span><\/p>","ID":"bf8e9a40-5223-42e8-9393-07030add292c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"5-10 St. Paul's\r Churchyard, ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">London EC4M 8AL <\/span><\/p>","ID":"ae25c81b-d99f-43d5-8013-8aff3497298c","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"London EC4M 8AL ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 (<\/span>0)\r 20 3289 9824<\/p>","ID":"82b3a9ee-8dc0-471b-bd15-7fc20c9f59c8","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Tel: +44 (0)\r 20 3289 9824","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Fax: +44 (<\/span><span style=\"color:#222222\">0) 20 3725 7789<\/span><\/p>","ID":"d0b85f4c-090d-4f67-b3a8-edaec26efeb6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Fax: +44 (0) 20 3725 7789","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">E<\/span><span lang=\"EN-GB\">-mail: safety@biocryst.com<\/span><\/p>","ID":"e943684e-2cbe-4a6b-b7ea-1e2b72b53de9","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"E-mail: safety@biocryst.com","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e70922be-3dde-42b3-8cec-e773e1697de9","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"10b3206f-a98c-4ed3-974c-fb4993c391a0","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><a name=\"_Hlk506824658\"><b><span lang=\"EN-GB\">8.       MARKETING\r AUTHORISATION NUMBER(S) <\/span><\/b><\/a><\/p>","ID":"9f586354-9608-4f21-94f5-ef54d85e606f","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"8.       MARKETING\r AUTHORISATION NUMBER(S) ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"52450120-2f70-478e-83d4-6e19c478a2ec","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU\/1\/18\/1269\/001<\/span><\/p>","ID":"df3a45fb-1889-4675-8385-7d01e762d185","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"EU\/1\/18\/1269\/001","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"ead106e7-ab2d-4e16-898a-83a3350adeb1","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"255bd75e-c96f-4242-bc3f-52de49bb9c00","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION\/RENEWAL OF THE\r AUTHORISATION<\/span><\/b><\/p>","ID":"16039a12-6822-4649-ab0d-e1ec262535b3","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"9.       DATE OF FIRST AUTHORISATION\/RENEWAL OF THE\r AUTHORISATION","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"11d58d47-8c89-4957-ac09-bb8e3ef933c7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d9f2b098-5f05-4dd7-a30a-e53fc71fd750","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT<\/span><\/b><\/p>","ID":"2f73b748-60c8-4999-b0a0-383ddab0d04a","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Classes":"['MsoNormal']","Bold":true,"Italics":false,"Uppercased":true,"Underlined":false,"Indexed":true,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":true,"IsHeadingType":"L1","Text":"10.     DATE OF REVISION OF THE TEXT","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"b58219c0-ea09-462e-900a-03038951f42a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\r website of the European Medicines Agency <span style=\"color:blue\">http:\/\/www.ema.europa.eu<\/span>.<br clear=\"all\" style=\"page-break-before:always\"\/> <\/span><\/p>","ID":"2b9f8ffe-11d7-43c3-964e-a993c181c6e6","Styles":"margin-right:-.1pt;line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"Detailed information on this medicinal product is available on the\r website of the European Medicines Agency http:\/\/www.ema.europa.eu. ","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"08b5d53c-0e29-4bb7-ad5e-b92a0a898e8a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"763edb08-aaf1-47a4-9388-c7aa17398f02","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"361eba29-a15e-4bed-8c4b-720860a7ec41","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"85eb834e-9119-4020-86e6-2442626ba797","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"acf79ad3-ff03-4877-a0f9-437e9ff2d392","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2751146a-861c-4beb-b205-727c06761536","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f39bf4f2-cc6e-4ca0-a0f2-da31eac60e78","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"f290843d-126a-45cc-92cf-e5ed456a0d75","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"7ffc5333-6cac-4397-9480-25afd4fabac4","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"a3b61887-06d9-4f3a-b530-3afe870b6ea6","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"75ccf73c-2c2f-46fa-bd78-018befe2dc9f","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d7dc3472-f24e-4049-be53-cf8ee1ad8666","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"d5014d52-c41a-404c-aaed-df196221b0b2","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"91164c26-8296-4c43-82b6-97377071cf71","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"2c15dc8b-fbbe-421f-b2b8-b145ccff7a01","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e4fbe8b1-0140-49f2-81f9-68feacf2c667","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"1dd5e110-0f9c-4f12-904f-db5336bcb9bd","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"48413b25-ae6b-4608-bf16-fe81a4b5e3d4","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"3eaf160e-75c1-4b44-bca0-44b4e4ee3272","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"fb6a4a79-9f91-4b62-8d0e-5a6093755286","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"e4891a61-ca3d-4868-8eff-5da826208f7a","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"08739571-9f80-4e12-97a2-0a91533377b7","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"},{"Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","ID":"71ee2b4d-82d7-4220-8c8a-97bf589c5b52","Styles":"line-height:normal","Classes":"['MsoNormal']","Bold":false,"Italics":false,"Uppercased":false,"Underlined":false,"Indexed":false,"IsListItem":false,"HasBorder":false,"IsPossibleHeading":false,"IsHeadingType":null,"Text":"","ParentId":"15201696-bd51-4bd4-896c-ae5a6f3618c7"}]